1
|
Pereira CM, de Carvalho AC, da Silva FR, Melendez ME, Lessa RC, Andrade VCC, Kowalski LP, Vettore AL, Carvalho AL. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer. BMC Cancer 2018; 18:193. [PMID: 29454310 PMCID: PMC5816396 DOI: 10.1186/s12885-018-4077-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2017] [Accepted: 01/29/2018] [Indexed: 12/31/2022] Open
Abstract
Background Aberrant methylation is a frequent event in oral cancer. Methods In order to better characterize these alterations, a search for genes downregulated by aberrant methylation in oral squamous cell carcinoma (OSCC) was conducted through the mining of ORESTES dataset. Findings were further validated in OSCC cell lines and patients’ samples and confirmed using TCGA data. Differentially expressed genes were identified in ORESTES libraries and validated in vitro using RT-PCR in HNSCC cell-lines and OSCC tumor samples. Further confirmation of these results was performed using mRNA expression and methylation data from The Cancer Genome Atlas (TCGA) data. Results From the set of genes selected for validation, CA3 and FHL1 were downregulated in 60% (12/20) and 75% (15/20) of OSCC samples, respectively, and in HNSCC cell lines. The treatment of cell lines JHU-13 and FaDu with the demethylating agent 5'-aza-dC was efficient in restoring CA3 and FHL1 expression. TCGA expression and methylation data on OSCC confirms the downregulation of these genes in OSCC samples and also suggests that expression of CA3 and FHL1 is probably regulated by methylation. The downregulation of CA3 and FHL1 observed in silico was validated in HNSCC cell lines and OSCC samples, showing the feasibility of integrating different datasets to select differentially expressed genes in silico. Conclusions These results showed that the downregulation of CA3 and FHL1 data observed in the ORESTES libraries was validated in HNSCC cell lines and OSCC samples and in a large cohort of samples from the TCGA database. Moreover, it suggests that expression of CA3 and FHL1 could probably be regulated by methylation having an important role the oral carcinogenesis. Electronic supplementary material The online version of this article (10.1186/s12885-018-4077-3) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Cláudia Maria Pereira
- Department of Head and Neck Surgery, A. C. Camargo Cancer Hospital, São Paulo, Brazil.,Laboratory of Cancer Genetics, Ludwig Institute for Cancer Research, Sao Paulo, Branch, Brazil
| | - Ana Carolina de Carvalho
- Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.,Department of Science Biology, Universidade Federal de São Paulo, UNIFESP, Diadema, Brazil
| | | | | | - Roberta Cardim Lessa
- Department of Head and Neck Surgery, A. C. Camargo Cancer Hospital, São Paulo, Brazil.,Laboratory of Cancer Genetics, Ludwig Institute for Cancer Research, Sao Paulo, Branch, Brazil
| | | | - Luiz Paulo Kowalski
- Department of Head and Neck Surgery, A. C. Camargo Cancer Hospital, São Paulo, Brazil
| | - André L Vettore
- Laboratory of Cancer Genetics, Ludwig Institute for Cancer Research, Sao Paulo, Branch, Brazil.,Department of Science Biology, Universidade Federal de São Paulo, UNIFESP, Diadema, Brazil
| | - André Lopes Carvalho
- Department of Head and Neck Surgery, A. C. Camargo Cancer Hospital, São Paulo, Brazil. .,Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil. .,Department of Head and Neck Surgery, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
| |
Collapse
|
2
|
Wang K, Chen Y. Analysis of a novel protein in human colorectal adenocarcinoma. Mol Med Rep 2013; 8:529-34. [PMID: 23778839 DOI: 10.3892/mmr.2013.1526] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2013] [Accepted: 05/29/2013] [Indexed: 11/05/2022] Open
Abstract
Colorectal adenocarcinoma (CRC) is the third most common type of cancer worldwide with a low 5‑year survival rate. The present study aimed to investigate the structure and function of a novel protein identified from human colorectal adenocarcinoma (CRC). A differentially expressed sequence tag (GenBank accession number, ES274081) was collected from GenBank. Bioinformatics tools were employed to obtain the sequence of the full‑length cDNA in order to localize the open reading frame and to predict the protein sequence. Mass spectro-metry was used to analyze the structure of this novel protein and western blot analysis was used to confirm the expression of this protein in human CRC tissue samples. The full‑length cDNA was composed of 4,283‑bp nucleotides and the sequence information was obtained (GenBank accession number, NM_001013649). The corresponding protein molecule contained 165 amino acids, with a monoisotopic molecular weight of 18.6033 kDa and an isoelectric point of 8.43, determined by mass spectrometry. The protein structure and its function in adenocarcinoma were further explored. In the present study, a novel protein, which may be involved in nuclear signal transduction, was identified using bioinformatics, mass spectrometry and western blot analysis.
Collapse
Affiliation(s)
- Kaicheng Wang
- Department of Anatomy, Premedical and Forensic Medical Institute, Sichuan University, Chengdu, Sichuan 610041, P.R. China
| | | |
Collapse
|
3
|
Lessa RC, Campos AHJFM, Freitas CED, Silva FRD, Kowalski LP, Carvalho AL, Vettore AL. Identification of upregulated genes in oral squamous cell carcinomas. Head Neck 2012; 35:1475-81. [PMID: 22987617 DOI: 10.1002/hed.23169] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
BACKGROUND Oral cancer is the most common subset of head and neck squamous cell carcinomas (HNSCC). These tumors often have an aggressive clinical outcome hallmarked by a propensity for local invasion and regional nodal metastasis. Upregulated genes could be useful as markers for diagnosis, prognosis, and as new drug targets for these tumors. METHODS To identify upregulated genes in oral squamous cell carcinomas (OSSCs), we examined the ORESTES public database and used a quantitative reverse transcription-polymerase chain reaction (qRT-PCR) approach to determine the expression level of selected genes in tumor samples. RESULTS AND CONCLUSIONS The ORESTES data mining analysis indicated 40 upregulated genes in HNSCC. Nine of these candidate genes were selected for further qRT-PCR validation and 3 of them (ALDOA, AHSA1, and POLQ) were frequently found upregulated in OSCC samples, which may indicate an association of these genes with the carcinogenesis process in this tumor site and they can constitute potential new targets for therapy.
Collapse
Affiliation(s)
- Roberta C Lessa
- Department of Head and Neck Surgery, A. C. Camargo Cancer Hospital, São Paulo, São Paulo, Brazil; Ludwig Institute for Cancer Research, São Paulo Branch, São Paulo, Brazil
| | | | | | | | | | | | | |
Collapse
|
4
|
Campos AHJFM, Silva AA, Mota LDDC, Olivieri ER, Prescinoti VC, Patrão D, Camargo LP, Brentani H, Carraro DM, Brentani RR, Soares FA. The Value of a Tumor Bank in the Development of Cancer Research in Brazil: 13 Years of Experience at the A C Camargo Hospital. Biopreserv Biobank 2012; 10:168-73. [DOI: 10.1089/bio.2011.0032] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Affiliation(s)
- Antonio Hugo Jose Froes Marques Campos
- A C Camargo Hospital Biobank, A C Camargo Hospital–Antonio Prudente Foundation, São Paulo, SP, Brazil
- A C Camargo Hospital Tumor Bank, A C Camargo Hospital–Antonio Prudente Foundation, São Paulo, SP, Brazil
- Department of Anatomic Pathology, A C Camargo Hospital–Antonio Prudente Foundation, São Paulo, SP, Brazil
| | - Andre Abreu Silva
- A C Camargo Hospital Tumor Bank, A C Camargo Hospital–Antonio Prudente Foundation, São Paulo, SP, Brazil
| | | | | | | | - Diogo Patrão
- Biotechnology Laboratory, A C Camargo Hospital–Antonio Prudente Foundation, São Paulo, SP, Brazil
| | - Luiz Paulo Camargo
- Biotechnology Laboratory, A C Camargo Hospital–Antonio Prudente Foundation, São Paulo, SP, Brazil
| | - Helena Brentani
- Biotechnology Laboratory, A C Camargo Hospital–Antonio Prudente Foundation, São Paulo, SP, Brazil
| | - Dirce Maria Carraro
- DNA & RNA Bank, A C Camargo Hospital–Antonio Prudente Foundation, São Paulo, SP, Brazil
| | - Ricardo Renzo Brentani
- Centro Internacional de Pesquisa e Ensino—CIPE, A C Camargo Hospital–Antonio Prudente Foundation, São Paulo, SP, Brazil
| | - Fernando Augusto Soares
- A C Camargo Hospital Tumor Bank, A C Camargo Hospital–Antonio Prudente Foundation, São Paulo, SP, Brazil
- Department of Anatomic Pathology, A C Camargo Hospital–Antonio Prudente Foundation, São Paulo, SP, Brazil
| |
Collapse
|
5
|
Barbieri MR, Andrade CD, Silva WA, Marques AA, Leopoldino AM, Montes MB, Dias-Baruffi M, Soares IC, Wakamatsu A, Alves VA, Laure HJ, Zago MA, Greene LJ. Expression of human protein S100A7 (psoriasin), preparation of antibody and application to human larynx squamous cell carcinoma. BMC Res Notes 2011; 4:494. [PMID: 22082027 PMCID: PMC3278597 DOI: 10.1186/1756-0500-4-494] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2011] [Accepted: 11/14/2011] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Up-regulation of S100A7 (Psoriasin), a small calcium-binding protein, is associated with the development of several types of carcinomas, but its function and possibility to serve as a diagnostic or prognostic marker have not been fully defined. In order to prepare antibodies to the protein for immunohistochemical studies we produced the recombinant S100A7 protein in E. coli. mRNA extracted from human tracheal tumor tissue which was amplified by RT-PCR to provide the region coding for the S100A7 gene. The amplified fragment was cloned in the vector pCR2.1-TOPO and sub-cloned in the expression vector pAE. The protein rS100A7 (His-tag) was expressed in E. coli BL21::DE3, purified by affinity chromatography on an Ni-NTA column, recovered in the 2.0 to 3.5 mg/mL range in culture medium, and used to produce a rabbit polyclonal antibody anti-rS100A7 protein. The profile of this polyclonal antibody was evaluated in a tissue microarray. RESULTS The rS100A7 (His-tag) protein was homogeneous by SDS-PAGE and mass spectrometry and was used to produce an anti-recombinant S100A7 (His-tag) rabbit serum (polyclonal antibody anti-rS100A7). The molecular weight of rS100A7 (His-tag) protein determined by linear MALDI-TOF-MS was 12,655.91 Da. The theoretical mass calculated for the nonapeptide attached to the amino terminus is 12,653.26 Da (delta 2.65 Da). Immunostaining with the polyclonal anti-rS100A7 protein generated showed reactivity with little or no background staining in head and neck squamous cell carcinoma cells, detecting S100A7 both in nucleus and cytoplasm. Lower levels of S100A7 were detected in non-neoplastic tissue. CONCLUSIONS The polyclonal anti-rS100A7 antibody generated here yielded a good signal-to-noise contrast and should be useful for immunohistochemical detection of S100A7 protein. Its potential use for other epithelial lesions besides human larynx squamous cell carcinoma and non-neoplastic larynx should be explored in future.
Collapse
Affiliation(s)
- Manuela R Barbieri
- Department of Clinical Medicine, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Tahira AC, Kubrusly MS, Faria MF, Dazzani B, Fonseca RS, Maracaja-Coutinho V, Verjovski-Almeida S, Machado MCC, Reis EM. Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Mol Cancer 2011; 10:141. [PMID: 22078386 PMCID: PMC3225313 DOI: 10.1186/1476-4598-10-141] [Citation(s) in RCA: 135] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2011] [Accepted: 11/13/2011] [Indexed: 12/29/2022] Open
Abstract
Background Pancreatic ductal adenocarcinoma (PDAC) is known by its aggressiveness and lack of effective therapeutic options. Thus, improvement in current knowledge of molecular changes associated with pancreatic cancer is urgently needed to explore novel venues of diagnostics and treatment of this dismal disease. While there is mounting evidence that long noncoding RNAs (lncRNAs) transcribed from intronic and intergenic regions of the human genome may play different roles in the regulation of gene expression in normal and cancer cells, their expression pattern and biological relevance in pancreatic cancer is currently unknown. In the present work we investigated the relative abundance of a collection of lncRNAs in patients' pancreatic tissue samples aiming at identifying gene expression profiles correlated to pancreatic cancer and metastasis. Methods Custom 3,355-element spotted cDNA microarray interrogating protein-coding genes and putative lncRNA were used to obtain expression profiles from 38 clinical samples of tumor and non-tumor pancreatic tissues. Bioinformatics analyses were performed to characterize structure and conservation of lncRNAs expressed in pancreatic tissues, as well as to identify expression signatures correlated to tissue histology. Strand-specific reverse transcription followed by PCR and qRT-PCR were employed to determine strandedness of lncRNAs and to validate microarray results, respectively. Results We show that subsets of intronic/intergenic lncRNAs are expressed across tumor and non-tumor pancreatic tissue samples. Enrichment of promoter-associated chromatin marks and over-representation of conserved DNA elements and stable secondary structure predictions suggest that these transcripts are generated from independent transcriptional units and that at least a fraction is under evolutionary selection, and thus potentially functional. Statistically significant expression signatures comprising protein-coding mRNAs and lncRNAs that correlate to PDAC or to pancreatic cancer metastasis were identified. Interestingly, loci harboring intronic lncRNAs differentially expressed in PDAC metastases were enriched in genes associated to the MAPK pathway. Orientation-specific RT-PCR documented that intronic transcripts are expressed in sense, antisense or both orientations relative to protein-coding mRNAs. Differential expression of a subset of intronic lncRNAs (PPP3CB, MAP3K14 and DAPK1 loci) in metastatic samples was confirmed by Real-Time PCR. Conclusion Our findings reveal sets of intronic lncRNAs expressed in pancreatic tissues whose abundance is correlated to PDAC or metastasis, thus pointing to the potential relevance of this class of transcripts in biological processes related to malignant transformation and metastasis in pancreatic cancer.
Collapse
Affiliation(s)
- Ana C Tahira
- Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, 05508-900, São Paulo, SP, Brasil
| | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Maschietto M, Trapé AP, Piccoli FS, Ricca TI, Dias AAM, Coudry RA, Galante PA, Torres C, Fahhan L, Lourenço S, Grundy PE, de Camargo B, de Souza S, Neves EJ, Soares FA, Brentani H, Carraro DM. Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset. Cell Death Dis 2011; 2:e224. [PMID: 22048167 PMCID: PMC3223691 DOI: 10.1038/cddis.2011.105] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Wilms' tumors (WTs) originate from metanephric blastema cells that are unable to complete differentiation, resulting in triphasic tumors composed of epithelial, stromal and blastemal cells, with the latter harboring molecular characteristics similar to those of the earliest kidney development stages. Precise regulation of Wnt and related signaling pathways has been shown to be crucial for correct kidney differentiation. In this study, the gene expression profile of Wnt and related pathways was assessed in laser-microdissected blastemal cells in WTs and differentiated kidneys, in human and in four temporal kidney differentiation stages (i.e. E15.5, E17.5, P1.5 and P7.5) in mice, using an orthologous cDNA microarray platform. A signaling pathway-based gene signature was shared between cells of WT and of earliest kidney differentiation stages, revealing genes involved in the interruption of blastemal cell differentiation in WT. Reverse transcription-quantitative PCR showed high robustness of the microarray data demonstrating 75 and 56% agreement in the initial and independent sample sets, respectively. The protein expression of CRABP2, IGF2, GRK7, TESK1, HDGF, WNT5B, FZD2 and TIMP3 was characterized in WTs and in a panel of human fetal kidneys displaying remarkable aspects of differentiation, which was recapitulated in the tumor. Taken together, this study reveals new genes candidate for triggering WT onset and for therapeutic treatment targets.
Collapse
Affiliation(s)
- M Maschietto
- Laboratory of Genomics and Molecular Biology, CIPE-AC Camargo Hospital, São Paulo, SP, Brasil
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Martins WK, Esteves GH, Almeida OM, Rezze GG, Landman G, Marques SM, Carvalho AF, L Reis LF, Duprat JP, Stolf BS. Gene network analyses point to the importance of human tissue kallikreins in melanoma progression. BMC Med Genomics 2011; 4:76. [PMID: 22032772 PMCID: PMC3212933 DOI: 10.1186/1755-8794-4-76] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2011] [Accepted: 10/27/2011] [Indexed: 12/15/2022] Open
Abstract
Background A wide variety of high-throughput microarray platforms have been used to identify molecular targets associated with biological and clinical tumor phenotypes by comparing samples representing distinct pathological states. Methods The gene expression profiles of human cutaneous melanomas were determined by cDNA microarray analysis. Next, a robust analysis to determine functional classifications and make predictions based on data-oriented hypotheses was performed. Relevant networks that may be implicated in melanoma progression were also considered. Results In this study we aimed to analyze coordinated gene expression changes to find molecular pathways involved in melanoma progression. To achieve this goal, ontologically-linked modules with coordinated expression changes in melanoma samples were identified. With this approach, we detected several gene networks related to different modules that were induced or repressed during melanoma progression. Among them we observed high coordinated expression levels of genes involved in a) cell communication (KRT4, VWF and COMP); b) epidermal development (KLK7, LAMA3 and EVPL); and c) functionally related to kallikreins (EVPL, KLK6, KLK7, KLK8, SERPINB13, SERPING1 and SLPI). Our data also indicated that hKLK7 protein expression was significantly associated with good prognosis and survival. Conclusions Our findings, derived from a different type of analysis of microarray data, highlight the importance of analyzing coordinated gene expression to find molecular pathways involved in melanoma progression.
Collapse
|
9
|
Coló AEL, Simoes ACQ, Carvalho AL, Melo CM, Fahham L, Kowalski LP, Soares FA, Neves EJ, Reis LFL, Carvalho AF. Functional microarray analysis suggests repressed cell-cell signaling and cell survival-related modules inhibit progression of head and neck squamous cell carcinoma. BMC Med Genomics 2011; 4:33. [PMID: 21489260 PMCID: PMC3095999 DOI: 10.1186/1755-8794-4-33] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2010] [Accepted: 04/13/2011] [Indexed: 01/22/2023] Open
Abstract
Background Cancer shows a great diversity in its clinical behavior which cannot be easily predicted using the currently available clinical or pathological markers. The identification of pathways associated with lymph node metastasis (N+) and recurrent head and neck squamous cell carcinoma (HNSCC) may increase our understanding of the complex biology of this disease. Methods Tumor samples were obtained from untreated HNSCC patients undergoing surgery. Patients were classified according to pathologic lymph node status (positive or negative) or tumor recurrence (recurrent or non-recurrent tumor) after treatment (surgery with neck dissection followed by radiotherapy). Using microarray gene expression, we screened tumor samples according to modules comprised by genes in the same pathway or functional category. Results The most frequent alterations were the repression of modules in negative lymph node (N0) and in non-recurrent tumors rather than induction of modules in N+ or in recurrent tumors. N0 tumors showed repression of modules that contain cell survival genes and in non-recurrent tumors cell-cell signaling and extracellular region modules were repressed. Conclusions The repression of modules that contain cell survival genes in N0 tumors reinforces the important role that apoptosis plays in the regulation of metastasis. In addition, because tumor samples used here were not microdissected, tumor gene expression data are represented together with the stroma, which may reveal signaling between the microenvironment and tumor cells. For instance, in non-recurrent tumors, extracellular region module was repressed, indicating that the stroma and tumor cells may have fewer interactions, which disable metastasis development. Finally, the genes highlighted in our analysis can be implicated in more than one pathway or characteristic, suggesting that therapeutic approaches to prevent tumor progression should target more than one gene or pathway, specially apoptosis and interactions between tumor cells and the stroma.
Collapse
Affiliation(s)
- Anna E L Coló
- Hospital AC Camargo, Rua Taguá, 440, São Paulo, SP, 01508-010, Brazil.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Martins C, Reis-Cunha J, Silva M, Pereira E, Pappas Jr. G, Bartholomeu D, Zingales B. Identification of genes encoding hypothetical proteins in open-reading frame expressed sequence tags from mammalian stages of Trypanosoma cruzi. GENETICS AND MOLECULAR RESEARCH 2011; 10:1589-630. [DOI: 10.4238/vol10-3gmr1140] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
11
|
Upstream - news in genomics. Comp Funct Genomics 2010; 2:355-8. [PMID: 18628866 PMCID: PMC2447225 DOI: 10.1002/cfg.125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
Since our last issue, several important genomes have been completely or ‘almost
completely’ sequenced. The debate over the number of human genes has flared up once
more, with one computational and one experimental study into the annotation of the
human genome. The mouse genome project has a clone fingerprint map to aid their
sequencing effort. The SAGE technique has been applied to Drosophila and the US
National Science Foundation announced increased spending on plant genome research.
Collapse
|
12
|
Almeida CR, Stoco PH, Wagner G, Sincero TC, Rotava G, Bayer-Santos E, Rodrigues JB, Sperandio MM, Maia AA, Ojopi EP, Zaha A, Ferreira HB, Tyler KM, Dávila AM, Grisard EC, Dias-Neto E. Transcriptome analysis of Taenia solium cysticerci using Open Reading Frame ESTs (ORESTES). Parasit Vectors 2009; 2:35. [PMID: 19646239 PMCID: PMC2731055 DOI: 10.1186/1756-3305-2-35] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2009] [Accepted: 07/31/2009] [Indexed: 12/31/2022] Open
Abstract
BACKGROUND Human infection by the pork tapeworm Taenia solium affects more than 50 million people worldwide, particularly in underdeveloped and developing countries. Cysticercosis which arises from larval encystation can be life threatening and difficult to treat. Here, we investigate for the first time the transcriptome of the clinically relevant cysticerci larval form. RESULTS Using Expressed Sequence Tags (ESTs) produced by the ORESTES method, a total of 1,520 high quality ESTs were generated from 20 ORESTES cDNA mini-libraries and its analysis revealed fragments of genes with promising applications including 51 ESTs matching antigens previously described in other species, as well as 113 sequences representing proteins with potential extracellular localization, with obvious applications for immune-diagnosis or vaccine development. CONCLUSION The set of sequences described here will contribute to deciphering the expression profile of this important parasite and will be informative for the genome assembly and annotation, as well as for studies of intra- and inter-specific sequence variability. Genes of interest for developing new diagnostic and therapeutic tools are described and discussed.
Collapse
Affiliation(s)
- Carolina R Almeida
- Laboratórios de Protozoologia e de Bioinformática, Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de Santa Catarina (UFSC), Caixa postal 476, CEP 88040-970, Florianópolis, SC, Brazil.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Berna A, Scott K, Chabrière E, Bernier F. The DING family of proteins: ubiquitous in eukaryotes, but where are the genes? Bioessays 2009; 31:570-80. [PMID: 19360767 DOI: 10.1002/bies.200800174] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
PstS and DING proteins are members of a superfamily of secreted, high-affinity phosphate-binding proteins. Whereas microbial PstS have a well-defined role in phosphate ABC transporters, the physiological function of DING proteins, named after their DINGGG N termini, still needs to be determined. PstS and DING proteins co-exist in some Pseudomonas strains, to which they confer a highly adhesive and virulent phenotype. More than 30 DING proteins have now been purified, mostly from eukaryotes. They are often associated with infections or with dysregulation of cell proliferation. Consequently, eukaryotic DING proteins could also be involved in cell-cell communication or adherence. The ubiquitous presence in eukaryotes of proteins structurally and functionally related to bacterial virulence factors is intriguing, as is the absence of eukaryotic genes encoding DING proteins in databases. DING proteins in eukaryotes could originate from unidentified commensal or symbiotic bacteria and could contribute to essential functions. Alternatively, DING proteins could be encoded by eukaryotic genes sharing special features that prevent their cloning. Both hypotheses are discussed.
Collapse
Affiliation(s)
- Anne Berna
- Institut de Biologie Moléculaire des Plantes du CNRS, Université Louis Pasteur, Institut de Botanique, Strasbourg Cedex, France
| | | | | | | |
Collapse
|
14
|
Wren JD. A global meta-analysis of microarray expression data to predict unknown gene functions and estimate the literature-data divide. ACTA ACUST UNITED AC 2009; 25:1694-701. [PMID: 19447786 DOI: 10.1093/bioinformatics/btp290] [Citation(s) in RCA: 78] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
MOTIVATION Approximately 9334 (37%) of human genes have no publications documenting their function and, for those that are published, the number of publications per gene is highly skewed. Furthermore, for reasons not clear, the entry of new gene names into the literature has slowed in recent years. If we are to better understand human/mammalian biology and complete the catalog of human gene function, it is important to finish predicting putative functions for these genes based upon existing experimental evidence. RESULTS A global meta-analysis (GMA) of all publicly available GEO two-channel human microarray datasets (3551 experiments total) was conducted to identify genes with recurrent, reproducible patterns of co-regulation across different conditions. Patterns of co-expression were divided into parallel (i.e. genes are up and down-regulated together) and anti-parallel. Several ranking methods to predict a gene's function based on its top 20 co-expressed gene pairs were compared. In the best method, 34% of predicted Gene Ontology (GO) categories matched exactly with the known GO categories for approximately 5000 genes analyzed versus only 3% for random gene sets. Only 2.4% of co-expressed gene pairs were found as co-occurring gene pairs in MEDLINE. CONCLUSIONS Via a GO enrichment analysis, genes co-expressed in parallel with the query gene were frequently associated with the same GO categories, whereas anti-parallel genes were not. Combining parallel and anti-parallel genes for analysis resulted in fewer significant GO categories, suggesting they are best analyzed separately. Expression databases contain much unexpected genetic knowledge that has not yet been reported in the literature. A total of 1642 Human genes with unknown function were differentially expressed in at least 30 experiments. AVAILABILITY Data matrix available upon request.
Collapse
Affiliation(s)
- Jonathan D Wren
- Arthritis and Immunology Research Program, Oklahoma Medical Research Foundation;, 825 N.E. 13th Street, Oklahoma City, OK 73104-5005, USA.
| |
Collapse
|
15
|
Aljamali MN, Hern L, Kupfer D, Downard S, So S, Roe BA, Sauer JR, Essenberg RC. Transcriptome analysis of the salivary glands of the female tick Amblyomma americanum (Acari: Ixodidae). INSECT MOLECULAR BIOLOGY 2009; 18:129-154. [PMID: 19320755 DOI: 10.1111/j.1365-2583.2009.00863.x] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Ticks infest a wide range of hosts while bypassing their immune, inflammatory and haemostatic responses during their extended feeding, which may last for more than two weeks. Here, we present a transcriptome analysis of 3868 expressed sequence tags (ESTs) from three cDNA libraries generated from the salivary glands of adult female Ambyomma americanum ticks at different stages of feeding. We applied a normalization step for one library, significantly decreasing the abundance of mitochondrial sequences amongst the 2292 sequences from the normalized library. Our ESTs include homologues that may modulate haemostatic, immune and inflammatory responses of the hosts. Other ESTs probably represent important components of the highly efficient secretory pathways for salivary proteins and concomitantly transmitted pathogens.
Collapse
Affiliation(s)
- M N Aljamali
- Department of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, USA
| | | | | | | | | | | | | | | |
Collapse
|
16
|
Mello BP, Abrantes EF, Torres CH, Machado-Lima A, Fonseca RDS, Carraro DM, Brentani RR, Reis LFL, Brentani H. No-match ORESTES explored as tumor markers. Nucleic Acids Res 2009; 37:2607-17. [PMID: 19270067 PMCID: PMC2677862 DOI: 10.1093/nar/gkp074] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
Sequencing technologies and new bioinformatics tools have led to the complete sequencing of various genomes. However, information regarding the human transcriptome and its annotation is yet to be completed. The Human Cancer Genome Project, using ORESTES (open reading frame EST sequences) methodology, contributed to this objective by generating data from about 1.2 million expressed sequence tags. Approximately 30% of these sequences did not align to ESTs in the public databases and were considered no-match ORESTES. On the basis that a set of these ESTs could represent new transcripts, we constructed a cDNA microarray. This platform was used to hybridize against 12 different normal or tumor tissues. We identified 3421 transcribed regions not associated with annotated transcripts, representing 83.3% of the platform. The total number of differentially expressed sequences was 1007. Also, 28% of analyzed sequences could represent noncoding RNAs. Our data reinforces the knowledge of the human genome being pervasively transcribed, and point out molecular marker candidates for different cancers. To reinforce our data, we confirmed, by real-time PCR, the differential expression of three out of eight potentially tumor markers in prostate tissues. Lists of 1007 differentially expressed sequences, and the 291 potentially noncoding tumor markers were provided.
Collapse
Affiliation(s)
- Barbara P Mello
- Hospital A. C. Camargo, Rua Prof. Antônio Prudente 211, São Paulo, SP, Brazil
| | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line. Proc Natl Acad Sci U S A 2009; 106:1886-91. [PMID: 19181860 DOI: 10.1073/pnas.0812945106] [Citation(s) in RCA: 93] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
We have identified new genomic alterations in the breast cancer cell line HCC1954, using high-throughput transcriptome sequencing. With 120 Mb of cDNA sequences, we were able to identify genomic rearrangement events leading to fusions or truncations of genes including MRE11 and NSD1, genes already implicated in oncogenesis, and 7 rearrangements involving other additional genes. This approach demonstrates that high-throughput transcriptome sequencing is an effective strategy for the characterization of genomic rearrangements in cancers.
Collapse
|
18
|
de Souza SJ. Exploiting ESTs in human health. Methods Mol Biol 2009; 533:311-324. [PMID: 19277565 DOI: 10.1007/978-1-60327-136-3_15] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Expressed Sequence Tags (ESTs) are fragments of cDNA clones. They correspond to the most abundant type of cDNA information available in the public databases. ESTs have been used for expression profiling, gene identification, characterization of differentially expressed genes, and identification of transcript variants among other utilities. In this review I will discuss the major features of the collection of ESTs available in the public domain giving a special emphasis on how this dataset has been used in studies about human diseases.
Collapse
|
19
|
Matukumalli LK, Schroeder SG. Sequence Based Gene Expression Analysis. Bioinformatics 2009. [DOI: 10.1007/978-0-387-92738-1_9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
20
|
Brito GC, Fachel AA, Vettore AL, Vignal GM, Gimba ERP, Campos FS, Barcinski MA, Verjovski-Almeida S, Reis EM. Identification of protein-coding and intronic noncoding RNAs down-regulated in clear cell renal carcinoma. Mol Carcinog 2008; 47:757-67. [PMID: 18348187 DOI: 10.1002/mc.20433] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
The clear cell subtype of renal cell carcinoma (RCC) is the most lethal and prevalent cancer of the urinary system. To investigate the molecular changes associated with malignant transformation in clear cell RCC, the gene expression profiles of matched samples of tumor and adjacent non-neoplastic tissue were obtained from six patients. A custom-built cDNA microarray platform was used, comprising 2292 probes that map to exons of genes and 822 probes for noncoding RNAs mapping to intronic regions. Intronic transcription was detected in all normal and neoplastic renal tissues. A subset of 55 transcripts was significantly down-regulated in clear cell RCC relative to the matched nontumor tissue as determined by a combination of two statistical tests and leave-one-out patient cross-validation. Among the down-regulated transcripts, 49 mapped to untranslated or coding exons and 6 were intronic relative to known exons of protein-coding genes. Lower levels of expression of SIN3B, TRIP3, SYNJ2BP and NDE1 (P < 0.02), and of intronic transcripts derived from SND1 and ACTN4 loci (P < 0.05), were confirmed in clear cell RCC by Real-time RT-PCR. A subset of 25 transcripts was deregulated in additional six nonclear cell RCC samples, pointing to common transcriptional alterations in RCC irrespective of the histological subtype or differentiation state of the tumor. Our results indicate a novel set of tumor suppressor gene candidates, including noncoding intronic RNAs, which may play a significant role in malignant transformations of normal renal cells.
Collapse
Affiliation(s)
- Glauber Costa Brito
- Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, SP, Brazil
| | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Luo Y, Xu X, Ding Z, Liu Z, Zhang B, Yan Z, Sun J, Hu S, Hu X. Complete genome of Phenylobacterium zucineum--a novel facultative intracellular bacterium isolated from human erythroleukemia cell line K562. BMC Genomics 2008; 9:386. [PMID: 18700039 PMCID: PMC2529317 DOI: 10.1186/1471-2164-9-386] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2007] [Accepted: 08/13/2008] [Indexed: 11/24/2022] Open
Abstract
Background Phenylobacterium zucineum is a recently identified facultative intracellular species isolated from the human leukemia cell line K562. Unlike the known intracellular pathogens, P. zucineum maintains a stable association with its host cell without affecting the growth and morphology of the latter. Results Here, we report the whole genome sequence of the type strain HLK1T. The genome consists of a circular chromosome (3,996,255 bp) and a circular plasmid (382,976 bp). It encodes 3,861 putative proteins, 42 tRNAs, and a 16S-23S-5S rRNA operon. Comparative genomic analysis revealed that it is phylogenetically closest to Caulobacter crescentus, a model species for cell cycle research. Notably, P. zucineum has a gene that is strikingly similar, both structurally and functionally, to the cell cycle master regulator CtrA of C. crescentus, and most of the genes directly regulated by CtrA in the latter have orthologs in the former. Conclusion This work presents the first complete bacterial genome in the genus Phenylobacterium. Comparative genomic analysis indicated that the CtrA regulon is well conserved between C. crescentus and P. zucineum.
Collapse
Affiliation(s)
- Yingfeng Luo
- Cancer Institute, (Key Laboratory for Cancer Intervention and Prevention, Key Laboratory of Molecular Biology in Medical Sciences), Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China.
| | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Hanelt B, Lun CM, Adema CM. Comparative ORESTES-sampling of transcriptomes of immune-challenged Biomphalaria glabrata snails. J Invertebr Pathol 2008; 99:192-203. [PMID: 18590737 DOI: 10.1016/j.jip.2008.06.002] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2008] [Revised: 05/28/2008] [Accepted: 06/03/2008] [Indexed: 10/22/2022]
Abstract
The snail Biomphalaria glabrata (Gastropoda, Mollusca) is an important intermediate host for the human parasite Schistosoma mansoni (Digenea, Trematoda). Anti-pathogen responses of B. glabrata were studied towards a better understanding of snail immunity and host-parasite compatibility. Open reading frame ESTs (ORESTES) were sampled from different transcriptomes of M line strain B. glabrata, 12h post-challenge with Escherichia coli (Gram-negative), Micrococcus luteus (Gram-positive) bacteria or compatible S. mansoni, and controls. The resulting 3123 ORESTES represented 2129 unique sequences (373 clusters, 1756 singletons). Of these, 175 (8.1%) were putative defense factors, including lectins, antimicrobial peptides and components of various immune-effector systems. Comparison of biological processes (GO-terms) within different transcriptomes indicated that B. glabrata increased oxygen transport and metal binding in reaction to all challenges. Comprehensive comparisons of transcriptomes revealed that responses of B. glabrata against bacteria were similar to each other and differed from the ineffective response to S. mansoni. Furthermore, the response to S. mansoni infection was less comprehensive than that to bacteria. Many novel (unknown) sequences were recovered in association with particular challenges. B. glabrata possesses multi-faceted, potent immune defenses. This agrees with the notion that S. mansoni is capable of immune-evasion and prevents effective host defense responses in order to survive in B. glabrata. Future analysis of the numerous unknown sequences recovered from challenged snails may reveal novel immune factors and provide increased understanding of immunity of B. glabrata in relation to parasite-host compatibility.
Collapse
Affiliation(s)
- Ben Hanelt
- Center for Evolutionary and Theoretical Immunology, Department of Biology, MSC03 2020, University of New Mexico, 269 Castetter Hall, Albuquerque, NM 87131, USA.
| | | | | |
Collapse
|
23
|
Gorodkin J, Cirera S, Hedegaard J, Gilchrist MJ, Panitz F, Jørgensen C, Scheibye-Knudsen K, Arvin T, Lumholdt S, Sawera M, Green T, Nielsen BJ, Havgaard JH, Rosenkilde C, Wang J, Li H, Li R, Liu B, Hu S, Dong W, Li W, Yu J, Wang J, Stærfeldt HH, Wernersson R, Madsen LB, Thomsen B, Hornshøj H, Bujie Z, Wang X, Wang X, Bolund L, Brunak S, Yang H, Bendixen C, Fredholm M. Porcine transcriptome analysis based on 97 non-normalized cDNA libraries and assembly of 1,021,891 expressed sequence tags. Genome Biol 2007; 8:R45. [PMID: 17407547 PMCID: PMC1895994 DOI: 10.1186/gb-2007-8-4-r45] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2006] [Revised: 01/18/2007] [Accepted: 04/02/2007] [Indexed: 12/05/2022] Open
Abstract
A resource consisting of one million porcine ESTs is described, providing an essential resource for annotation, comparative genomics, assembly of the pig genome sequence, and further porcine transcription studies. Background Knowledge of the structure of gene expression is essential for mammalian transcriptomics research. We analyzed a collection of more than one million porcine expressed sequence tags (ESTs), of which two-thirds were generated in the Sino-Danish Pig Genome Project and one-third are from public databases. The Sino-Danish ESTs were generated from one normalized and 97 non-normalized cDNA libraries representing 35 different tissues and three developmental stages. Results Using the Distiller package, the ESTs were assembled to roughly 48,000 contigs and 73,000 singletons, of which approximately 25% have a high confidence match to UniProt. Approximately 6,000 new porcine gene clusters were identified. Expression analysis based on the non-normalized libraries resulted in the following findings. The distribution of cluster sizes is scaling invariant. Brain and testes are among the tissues with the greatest number of different expressed genes, whereas tissues with more specialized function, such as developing liver, have fewer expressed genes. There are at least 65 high confidence housekeeping gene candidates and 876 cDNA library-specific gene candidates. We identified differential expression of genes between different tissues, in particular brain/spinal cord, and found patterns of correlation between genes that share expression in pairs of libraries. Finally, there was remarkable agreement in expression between specialized tissues according to Gene Ontology categories. Conclusion This EST collection, the largest to date in pig, represents an essential resource for annotation, comparative genomics, assembly of the pig genome sequence, and further porcine transcription studies.
Collapse
Affiliation(s)
- Jan Gorodkin
- Division of Genetics and Bioinformatics, IBHV, Grønnegärdsvej 3, The Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C, Denmark
| | - Susanna Cirera
- Division of Genetics and Bioinformatics, IBHV, Grønnegärdsvej 3, The Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C, Denmark
| | - Jakob Hedegaard
- Department of Genetics and Biotechnology, Danish Institute of Agricultural Sciences, Blichers Alle, DK-8830 Tjele, Denmark
| | - Michael J Gilchrist
- The Wellcome Trust/Cancer Research UK Gurdon Institute, Cambridge, CB2 1QN, UK
| | - Frank Panitz
- Department of Genetics and Biotechnology, Danish Institute of Agricultural Sciences, Blichers Alle, DK-8830 Tjele, Denmark
| | - Claus Jørgensen
- Division of Genetics and Bioinformatics, IBHV, Grønnegärdsvej 3, The Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C, Denmark
| | - Karsten Scheibye-Knudsen
- Division of Genetics and Bioinformatics, IBHV, Grønnegärdsvej 3, The Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C, Denmark
| | - Troels Arvin
- Division of Genetics and Bioinformatics, IBHV, Grønnegärdsvej 3, The Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C, Denmark
| | - Steen Lumholdt
- Division of Genetics and Bioinformatics, IBHV, Grønnegärdsvej 3, The Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C, Denmark
| | - Milena Sawera
- Division of Genetics and Bioinformatics, IBHV, Grønnegärdsvej 3, The Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C, Denmark
| | - Trine Green
- Division of Genetics and Bioinformatics, IBHV, Grønnegärdsvej 3, The Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C, Denmark
| | - Bente J Nielsen
- Division of Genetics and Bioinformatics, IBHV, Grønnegärdsvej 3, The Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C, Denmark
| | - Jakob H Havgaard
- Division of Genetics and Bioinformatics, IBHV, Grønnegärdsvej 3, The Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C, Denmark
| | - Carina Rosenkilde
- Division of Genetics and Bioinformatics, IBHV, Grønnegärdsvej 3, The Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C, Denmark
| | - Jun Wang
- Beijing Genomics Institute, The Airport Industrial Road, Beijing 101300, PR China
- Institute of Human Genetics, University of Aarhus, Nordre Ringgade 1, DK-8000 Aarhus C, Denmark
- Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campus Vej 55, DK-5230 Odense M, Denmark
| | - Heng Li
- Beijing Genomics Institute, The Airport Industrial Road, Beijing 101300, PR China
- Institute of Human Genetics, University of Aarhus, Nordre Ringgade 1, DK-8000 Aarhus C, Denmark
| | - Ruiqiang Li
- Beijing Genomics Institute, The Airport Industrial Road, Beijing 101300, PR China
- Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campus Vej 55, DK-5230 Odense M, Denmark
| | - Bin Liu
- Beijing Genomics Institute, The Airport Industrial Road, Beijing 101300, PR China
| | - Songnian Hu
- Beijing Genomics Institute, The Airport Industrial Road, Beijing 101300, PR China
| | - Wei Dong
- Beijing Genomics Institute, The Airport Industrial Road, Beijing 101300, PR China
| | - Wei Li
- Beijing Genomics Institute, The Airport Industrial Road, Beijing 101300, PR China
| | - Jun Yu
- Beijing Genomics Institute, The Airport Industrial Road, Beijing 101300, PR China
| | - Jian Wang
- Beijing Genomics Institute, The Airport Industrial Road, Beijing 101300, PR China
| | - Hans-Henrik Stærfeldt
- Center for Biological Sequence Analysis, BioCentrum-DTU, Building 208, DK-2800 Lyngby, Denmark
| | - Rasmus Wernersson
- Center for Biological Sequence Analysis, BioCentrum-DTU, Building 208, DK-2800 Lyngby, Denmark
| | - Lone B Madsen
- Department of Genetics and Biotechnology, Danish Institute of Agricultural Sciences, Blichers Alle, DK-8830 Tjele, Denmark
| | - Bo Thomsen
- Department of Genetics and Biotechnology, Danish Institute of Agricultural Sciences, Blichers Alle, DK-8830 Tjele, Denmark
| | - Henrik Hornshøj
- Department of Genetics and Biotechnology, Danish Institute of Agricultural Sciences, Blichers Alle, DK-8830 Tjele, Denmark
| | - Zhan Bujie
- Department of Genetics and Biotechnology, Danish Institute of Agricultural Sciences, Blichers Alle, DK-8830 Tjele, Denmark
| | - Xuegang Wang
- Department of Genetics and Biotechnology, Danish Institute of Agricultural Sciences, Blichers Alle, DK-8830 Tjele, Denmark
| | - Xuefei Wang
- Department of Genetics and Biotechnology, Danish Institute of Agricultural Sciences, Blichers Alle, DK-8830 Tjele, Denmark
| | - Lars Bolund
- Beijing Genomics Institute, The Airport Industrial Road, Beijing 101300, PR China
- Institute of Human Genetics, University of Aarhus, Nordre Ringgade 1, DK-8000 Aarhus C, Denmark
| | - Søren Brunak
- Center for Biological Sequence Analysis, BioCentrum-DTU, Building 208, DK-2800 Lyngby, Denmark
| | - Huanming Yang
- Beijing Genomics Institute, The Airport Industrial Road, Beijing 101300, PR China
| | - Christian Bendixen
- Department of Genetics and Biotechnology, Danish Institute of Agricultural Sciences, Blichers Alle, DK-8830 Tjele, Denmark
| | - Merete Fredholm
- Division of Genetics and Bioinformatics, IBHV, Grønnegärdsvej 3, The Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C, Denmark
| |
Collapse
|
24
|
Identification of unannotated exons of low abundance transcripts in Drosophila melanogaster and cloning of a new serine protease gene upregulated upon injury. BMC Genomics 2007; 8:249. [PMID: 17650329 PMCID: PMC1949825 DOI: 10.1186/1471-2164-8-249] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2006] [Accepted: 07/24/2007] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND The sequencing of the D.melanogaster genome revealed an unexpected small number of genes (~ 14,000) indicating that mechanisms acting on generation of transcript diversity must have played a major role in the evolution of complex metazoans. Among the most extensively used mechanisms that accounts for this diversity is alternative splicing. It is estimated that over 40% of Drosophila protein-coding genes contain one or more alternative exons. A recent transcription map of the Drosophila embryogenesis indicates that 30% of the transcribed regions are unannotated, and that 1/3 of this is estimated as missed or alternative exons of previously characterized protein-coding genes. Therefore, the identification of the variety of expressed transcripts depends on experimental data for its final validation and is continuously being performed using different approaches. We applied the Open Reading Frame Expressed Sequence Tags (ORESTES) methodology, which is capable of generating cDNA data from the central portion of rare transcripts, in order to investigate the presence of hitherto unnanotated regions of Drosophila transcriptome. RESULTS Bioinformatic analysis of 1,303 Drosophila ORESTES clusters identified 68 sequences derived from unannotated regions in the current Drosophila genome version (4.3). Of these, a set of 38 was analysed by polyA+ northern blot hybridization, validating 17 (50%) new exons of low abundance transcripts. For one of these ESTs, we obtained the cDNA encompassing the complete coding sequence of a new serine protease, named SP212. The SP212 gene is part of a serine protease gene cluster located in the chromosome region 88A12-B1. This cluster includes the predicted genes CG9631, CG9649 and CG31326, which were previously identified as up-regulated after immune challenges in genomic-scale microarray analysis. In agreement with the proposal that this locus is co-regulated in response to microorganisms infection, we show here that SP212 is also up-regulated upon injury. CONCLUSION Using the ORESTES methodology we identified 17 novel exons from low abundance Drosophila transcripts, and through a PCR approach the complete CDS of one of these transcripts was defined. Our results show that the computational identification and manual inspection are not sufficient to annotate a genome in the absence of experimentally derived data.
Collapse
|
25
|
Abel U, Deichmann A, Bartholomae C, Schwarzwaelder K, Glimm H, Howe S, Thrasher A, Garrigue A, Hacein-Bey-Abina S, Cavazzana-Calvo M, Fischer A, Jaeger D, von Kalle C, Schmidt M. Real-time definition of non-randomness in the distribution of genomic events. PLoS One 2007; 2:e570. [PMID: 17593969 PMCID: PMC1892803 DOI: 10.1371/journal.pone.0000570] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2007] [Accepted: 06/06/2007] [Indexed: 11/18/2022] Open
Abstract
Features such as mutations or structural characteristics can be non-randomly or non-uniformly distributed within a genome. So far, computer simulations were required for statistical inferences on the distribution of sequence motifs. Here, we show that these analyses are possible using an analytical, mathematical approach. For the assessment of non-randomness, our calculations only require information including genome size, number of (sampled) sequence motifs and distance parameters. We have developed computer programs evaluating our analytical formulas for the real-time determination of expected values and p-values. This approach permits a flexible cluster definition that can be applied to most effectively identify non-random or non-uniform sequence motif distribution. As an example, we show the effectivity and reliability of our mathematical approach in clinical retroviral vector integration site distribution.
Collapse
Affiliation(s)
- Ulrich Abel
- Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany
- Department of Medical Biostatistics, Tumor Center Heidelberg-Mannheim, Heidelberg, Germany
| | - Annette Deichmann
- Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany
| | - Cynthia Bartholomae
- Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany
| | - Kerstin Schwarzwaelder
- Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany
| | - Hanno Glimm
- Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany
| | - Steven Howe
- Department of Medical Biostatistics, Tumor Center Heidelberg-Mannheim, Heidelberg, Germany
| | - Adrian Thrasher
- Molecular Immunology Unit, Institute of Child Health, University College London, London, United Kingdom
- Department of Clinical Immunology, Great Ormond Street Hospital NHS Trust, London, United Kingdom
| | - Alexandrine Garrigue
- INSERM Unit 768, Hôpital Necker and Faculté de Médecine Université René Descartes Paris V., Paris, France
| | - Salima Hacein-Bey-Abina
- INSERM Unit 768, Hôpital Necker and Faculté de Médecine Université René Descartes Paris V., Paris, France
- Département de Biothérapies, Hôpital Necker, Paris, France
| | - Marina Cavazzana-Calvo
- INSERM Unit 768, Hôpital Necker and Faculté de Médecine Université René Descartes Paris V., Paris, France
- Département de Biothérapies, Hôpital Necker, Paris, France
| | - Alain Fischer
- INSERM Unit 768, Hôpital Necker and Faculté de Médecine Université René Descartes Paris V., Paris, France
- Unité d'Immunologie et d'Hématologie Pédiatriques, Hôpital Necker, Paris, France
| | - Dirk Jaeger
- Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany
| | - Christof von Kalle
- Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany
- Division of Experimental Hematology, Cincinnati Childrens Research Foundation, Cincinnati, Ohio, United States of America
- * To whom correspondence should be addressed. E-mail: (CK); (MS)
| | - Manfred Schmidt
- Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany
- * To whom correspondence should be addressed. E-mail: (CK); (MS)
| |
Collapse
|
26
|
Avedissian M, Longo BM, Jaqueta CB, Schnabel B, Paiva PB, Mello LEAM, Briones MRS. Hippocampal gene expression analysis using the ORESTES methodology shows that homer 1a mRNA is upregulated in the acute period of the pilocarpine epilepsy model. Hippocampus 2007; 17:130-6. [PMID: 17146775 DOI: 10.1002/hipo.20248] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
In the study of temporal lobe epilepsy (TLE) the characterization of genes expressed in the hippocampus is of central importance for understanding their roles in epileptogenic mechanisms. Although several large-scale studies on TLE gene expression have been reported, precise assignment of individual genes associated with this syndrome is still debatable. Here we investigated differentially expressed genes by comparison of mRNAs from normal and epileptic rat hippocampus in the pilocarpine model of epilepsy. For this we used a powerful EST sequencing methodology, ORESTES (Open Reading frame Expressed Sequence Tags), which generates sequence datasets enriched for mRNAs open reading frames (ORFs) rather than simple 5' and 3' ends of mRNAs. Analysis of our sequences shows that ORESTES readily enables the identification of epilepsy associated ORFs. PFAM analysis of protein motifs present in our ORESTES epilepsy database revealed diverse important protein family domains, such as cytoskeletal, cell signaling and protein kinase domains, which could be involved in processes underlying epileptogenesis. More importantly, we show that the expression of homer 1a, known to be coupled to mGluR and NMDA synaptic transmission, is associated with pilocarpine induced status epilepticus (SE). The combined use of the pilocarpine model of epilepsy with the ORESTES technique can significantly contribute to the identification of specific genes and proteins related to TLE. This is the first study applying a large-scale method for rapid shotgun sequencing directed to ORFs in epilepsy research.
Collapse
|
27
|
Lockyer AE, Spinks JN, Walker AJ, Kane RA, Noble LR, Rollinson D, Dias-Neto E, Jones CS. Biomphalaria glabrata transcriptome: identification of cell-signalling, transcriptional control and immune-related genes from open reading frame expressed sequence tags (ORESTES). DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY 2007; 31:763-82. [PMID: 17208299 PMCID: PMC1871615 DOI: 10.1016/j.dci.2006.11.004] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/04/2006] [Revised: 11/06/2006] [Accepted: 11/08/2006] [Indexed: 05/13/2023]
Abstract
Biomphalaria glabrata is the major intermediate snail host for Schistosoma mansoni, one of the important schistosomes infecting man. Much remains to be discovered concerning specific molecules mediating the defence events in these intermediate hosts, triggered by invading schistosomes. An expressed sequence tag (EST) gene discovery strategy known as ORESTES has been employed to identify transcripts that might be involved in snail-schistosome interactions in order to examine gene expression patterns in infected B. glabrata. Over 3930 ESTs were sequenced from cDNA libraries made from both schistosome-exposed and unexposed snails using different tissue types, producing a database of 1843 non-redundant clones. The non-redundant set has been assessed for gene ontology and KEGG pathway assignments. This approach has revealed a number of signalling, antioxidant and immune-related gene homologues that, based on current understanding of molluscan and other comparative systems, might play an important role in the molluscan defence response towards infection.
Collapse
Affiliation(s)
- Anne E Lockyer
- Wolfson Wellcome Biomedical Laboratory, The Natural History Museum, Cromwell Road, London SW7 5BD, UK.
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Kim YC, Jung YC, Xuan Z, Dong H, Zhang MQ, Wang SM. Pan-genome isolation of low abundance transcripts using SAGE tag. FEBS Lett 2006; 580:6721-9. [PMID: 17113583 PMCID: PMC1791009 DOI: 10.1016/j.febslet.2006.11.013] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2006] [Revised: 10/31/2006] [Accepted: 11/03/2006] [Indexed: 11/24/2022]
Abstract
The SAGE (serial analysis of gene expression) method is sensitive at detecting the lower abundance transcripts. More than a third of human SAGE tags identified are novel representing the low abundance unknown transcripts. Using the GLGI method (generation of longer 3' EST from SAGE tag for gene identification), we converted 1009 low-copy, human X chromosome-specific SAGE tags into 10210 3' ESTs. We identified 3418 unique 3' ESTs, 46% of which are novel and originated from the lower abundance transcripts. However, nearly all 3' ESTs were mapped to various regions across the genome but not X chromosome. Detailed analysis indicates that those 3' ESTs were isolated by SAGE tag mis-priming to the non-parent transcripts. Replacing SAGE tags with non-transcribed genomic DNA tags resulted in poor amplification, indicating that the sequence similarity between different transcripts contributed to the amplification. Our study shows the prevalence of novel low abundance transcripts that can be isolated efficiently through SAGE tags mis-priming.
Collapse
Affiliation(s)
- Yeong Cheol Kim
- Center for Functional Genomics, Division of Medical Genetics, Department of Medicine, ENH Research Institute, Northwestern University, Evanston, IL 60201, USA
| | | | | | | | | | | |
Collapse
|
29
|
Pontes ER, Matos LC, da Silva EA, Xavier LS, Diaz BL, Small IA, Reis EM, Verjovski-Almeida S, Barcinski MA, Gimba ERP. Auto-antibodies in prostate cancer: humoral immune response to antigenic determinants coded by the differentially expressed transcripts FLJ23438 and VAMP3. Prostate 2006; 66:1463-73. [PMID: 16897729 DOI: 10.1002/pros.20439] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
BACKGROUND Here we evaluate auto-antibody response against two potential antigenic determinants of genes highly expressed in low Gleason Score prostate cancer (PC) tumor samples, namely FLJ23438 and VAMP3. METHODS RT-PCR assays were used to analyze mRNA expression profiles of FLJ23438 and VAMP3 transcripts. The auto-antibody response against FLJ23438 and VAMP3 recombinant proteins was tested by immunoblot assays using PC, benign prostate hyperplasia (BPH), healthy donors (HD), and other human cancers plasma samples. RESULTS Our data showed that 37% (10/27) and 7.4% (2/27) of PC plasma samples presented auto-antibodies against FLJ23438 and VAMP3, respectively. Only 8.3% (1/12) of BPH plasma samples were reactive for both auto-antibodies, while none (0/12) of HD plasma samples tested were reactive. CONCLUSIONS The prevalence of 37% of positive PC plasma samples for anti-FLJ23438 antibodies suggests that humoral immune response against this antigenic determinant could be a potential serum marker for this cancer.
Collapse
Affiliation(s)
- E R Pontes
- Instituto Nacional de Câncer/MS, Coordenação de Pesquisa, Divisão de Medicina Experimental, Biologia Celular e Pesquisa Clínica, Rio de Janeiro, Brasil
| | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Guimarães GS, Latini FRM, Camacho CP, Maciel RMB, Dias-Neto E, Cerutti JM. Identification of candidates for tumor-specific alternative splicing in the thyroid. Genes Chromosomes Cancer 2006; 45:540-53. [PMID: 16493598 DOI: 10.1002/gcc.20316] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Alternative splicing is the differential processing of exon junctions to produce a new transcript variant from one gene. Some aberrant splicing, however, has been shown to be cancer specific. Identification of these specific splice variations will provide important insight into the molecular mechanism of normal cellular physiology as well as the disease processes. To gain knowledge about whether alternative splicing is linked to thyroid tumorigenesis, we used our prediction database to select targets for analysis. Fifteen putatively new alternative splicing isoforms were selected on the basis of their expression in thyroid libraries and/or their origin in genes previously associated with carcinogenesis. Using a set of 66 normal, benign, and malignant thyroid tissue samples, new splicing events were confirmed by RT-PCR for 13 of 15 genes (a validation rate of 87%). In addition, new alternative splicing isoforms not predicted by the system and not previously described in public databases were identified. Five genes (PTPN18, ABI3BP, PFDN5, SULF2, and ST5) presented new and/or additional unpredicted isoforms differentially expressed between malignant and benign or normal thyroid tissues, confirmed by sequencing. PTPN18, ABI3BP, and PFDN5 revealed a statistically significant differential splicing profile. In addition, real-time PCR analysis revealed that expression of an alternative PFDN5 variant was higher in malignant lesions than in benign lesions or normal tissues.
Collapse
Affiliation(s)
- Gustavo S Guimarães
- Laboratory of Molecular Endocrinology, Department of Medicine, Federal University of São Paulo, Brazil
| | | | | | | | | | | |
Collapse
|
31
|
Stolf BS, Santos MMS, Simao DF, Diaz JP, Cristo EB, Hirata R, Curado MP, Neves EJ, Kowalski LP, Carvalho AF. Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression. Cancer 2006; 106:1891-900. [PMID: 16565969 DOI: 10.1002/cncr.21826] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
BACKGROUND Nodules of the thyroid gland are observed frequently in patients who undergo ultrasound studies. The majority of these nodules are benign, corresponding to goiters or adenomas, and only a small fraction corresponds to carcinomas. Among thyroid tumors, the diagnosis of follicular adenocarcinomas by preoperative fine-needle aspiration biopsy is a major challenge, because it requires inspection of the entire capsule to differentiate it from adenoma. Consequently, large numbers of patients undergo unnecessary thyroidectomy. METHODS Using data from gene expression analysis, the authors applied Fisher linear discriminant analysis and searched for expression signatures of individual samples of adenomas and follicular carcinomas that could be used as molecular classifiers for the precise classification of malignant and nonmalignant lesions. RESULTS Fourteen trios of genes were described that fulfilled the criteria for the correct classification of 100% of samples. The robustness of these trios was verified by using leave-1-out cross-validation and bootstrap analyses. The results demonstrated that, by combining trios, better classifiers could be generated that correctly classified >92% of samples. CONCLUSIONS The strategy of classifiers based on individual signatures was a useful strategy for distinguishing between samples with very similar expression profiles.
Collapse
|
32
|
Abstract
The present review considered: (a) the factors that conditioned the early transition from non-life to life; (b) genome structure and complexity in prokaryotes, eukaryotes, and organelles; (c) comparative human chromosome genomics; and (d) the Brazilian contribution to some of these studies. Understanding the dialectical conflict between freedom and organization is fundamental to give meaning to the patterns and processes of organic evolution.
Collapse
Affiliation(s)
- Francisco M Salzano
- Departamento de Genética, Instituto de Biociências, Universidade Federal do Rio Grande do Sul, Caixa Postal 15053, 91501-970 Porto Alegre, RS, Brazil.
| |
Collapse
|
33
|
Brentani RR, Carraro DM, Verjovski-Almeida S, Reis EM, Neves EJ, de Souza SJ, Carvalho AF, Brentani H, Reis LFL. Gene expression arrays in cancer research: methods and applications. Crit Rev Oncol Hematol 2005; 54:95-105. [PMID: 15843092 DOI: 10.1016/j.critrevonc.2004.12.006] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/14/2004] [Indexed: 11/15/2022] Open
Abstract
During the last 5 years, the number of papers describing data obtained by microarray technology increased exponentially with about 3000 papers in 2003. Undoubtedly, cancer is by far the disease that received most of the attention as far as the amount of data generated. As array technology is rather new and highly dependent on bioinformatics, mathematics and statistics, a clear understanding of the knowledge and information derived from array-based experiments is not widely appreciated. We shall review herein some of the issues related to the construction of DNA arrays, quantities and heterogeneity of probes and targets, the consequences of the physical characteristics of the probes, data extraction and data analysis as well as the applications of array technology. Our goal is to bring to the general audience, some of the basics of array technology and its possible application in oncology. By discussing some of the basic aspects of the methodology, we hope to stimulate criticism concerning the conclusions proposed by authors, especially in the light of the very low degree of reproducibility already proven when commercially available platforms were compared . Regardless of its pitfalls, it is unquestionable that array technology will have a great impact in the management of cancer and its applications will range from the discovery of new drug targets, new molecular tools for diagnosis and prognosis as well as for a tailored treatment that will take into account the molecular determinants of a given tumor. Hence, we shall also highlight some of the already available and promising applications of array technology on the day-to-day practice of oncology.
Collapse
|
34
|
Watahiki A, Waki K, Hayatsu N, Shiraki T, Kondo S, Nakamura M, Sasaki D, Arakawa T, Kawai J, Harbers M, Hayashizaki Y, Carninci P. Libraries enriched for alternatively spliced exons reveal splicing patterns in melanocytes and melanomas. Nat Methods 2004; 1:233-9. [PMID: 15782199 DOI: 10.1038/nmeth719] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2004] [Accepted: 09/27/2004] [Indexed: 01/27/2023]
Abstract
It is becoming increasingly clear that alternative splicing enables the complex development and homeostasis of higher organisms. To gain a better understanding of how splicing contributes to regulatory pathways, we have developed an alternative splicing library approach for the identification of alternatively spliced exons and their flanking regions by alternative splicing sequence enriched tags sequencing. Here, we have applied our approach to mouse melan-c melanocyte and B16-F10Y melanoma cell lines, in which 5,401 genes were found to be alternatively spliced. These genes include those encoding important regulatory factors such as cyclin D2, Ilk, MAPK12, MAPK14, RAB4, melastatin 1 and previously unidentified splicing events for 436 genes. Real-time PCR further identified cell line-specific exons for Tmc6, Abi1, Sorbs1, Ndel1 and Snx16. Thus, the ASL approach proved effective in identifying splicing events, which suggest that alternative splicing is important in melanoma development.
Collapse
Affiliation(s)
- Akira Watahiki
- Genome Science Laboratory, RIKEN, Wako main campus, 2-1 Hirosawa, Wako, Saitama, 351-0198 Japan
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Brunoni D. Medical genetics services in the city of Sao Paulo, Brazil. Public Health Genomics 2004; 7:106-10. [PMID: 15539824 DOI: 10.1159/000080778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
The city of Sao Paulo is located in the center of a metropolitan area with nearly 18 million inhabitants and 300,000 births/year. The currently existing medical genetics services are unable to meet the demand, due to their insufficient physical and personnel infrastructure. Institutions and experts in medical genetics could give short training and refresher courses to health professionals to enable them to work in the public health network. The city has a reasonably well developed health care network, represented by the Single Health System (Sistema Unico de Saude - SUS) and by the Family Health Program (Programa de Saude da Familia - PSF). The financial resources for such actions originate in the budget of the managing agencies of such systems. The limitations of genetic services provided to the population of the city could be overcome in a short period of time by developing programs within the public health care network. The city has institutions, professionals and financial resources to make this project feasible. To that end, the competent authorities of the Sao Paulo State and City Secretariats of Health should take managerial responsibility for the genetic services in the city.
Collapse
Affiliation(s)
- Decio Brunoni
- Disciplina de Genética e Centro de Genética Médica, Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, Brazil.
| |
Collapse
|
36
|
Abstract
This special issue of Community Genetics reviews some of the most important developments in medical genetics in key countries of Latin America. Contributions to this issue were prepared for a special consultation of the World Health Organization held in Porto Alegre, Brazil, on June 19, 2003. Latin America is a region of medium- to low-income countries characterized by socioeconomic problems, with large segments of the population living in poverty and extreme disparities in the distribution of wealth. A rise in chronic diseases typical of the processes of industrialization and urbanization coexists with the persistence of nutritional and infectious diseases characteristic of poverty and underdevelopment. Over the last 2 decades of the 20th century, birth defects and genetic disorders have increased their share of morbidity and mortality, and tertiary-care-based genetic services have developed in urban areas. Although privatization of health care is eroding the public sector, the public institutions continue to be the main providers of genetic services for the bulk of the population and the leaders in research. The development of clinical genetics in the region is concentrated in tertiary-care centers in large cities, although a recent trend began extending genetic services to the community.
Collapse
|
37
|
The use of Open Reading frame ESTs (ORESTES) for analysis of the honey bee transcriptome. BMC Genomics 2004; 5:84. [PMID: 15527499 PMCID: PMC533872 DOI: 10.1186/1471-2164-5-84] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2004] [Accepted: 11/03/2004] [Indexed: 11/24/2022] Open
Abstract
Background The ongoing efforts to sequence the honey bee genome require additional initiatives to define its transcriptome. Towards this end, we employed the Open Reading frame ESTs (ORESTES) strategy to generate profiles for the life cycle of Apis mellifera workers. Results Of the 5,021 ORESTES, 35.2% matched with previously deposited Apis ESTs. The analysis of the remaining sequences defined a set of putative orthologs whose majority had their best-match hits with Anopheles and Drosophila genes. CAP3 assembly of the Apis ORESTES with the already existing 15,500 Apis ESTs generated 3,408 contigs. BLASTX comparison of these contigs with protein sets of organisms representing distinct phylogenetic clades revealed a total of 1,629 contigs that Apis mellifera shares with different taxa. Most (41%) represent genes that are in common to all taxa, another 21% are shared between metazoans (Bilateria), and 16% are shared only within the Insecta clade. A set of 23 putative genes presented a best match with human genes, many of which encode factors related to cell signaling/signal transduction. 1,779 contigs (52%) did not match any known sequence. Applying a correction factor deduced from a parallel analysis performed with Drosophila melanogaster ORESTES, we estimate that approximately half of these no-match ESTs contigs (22%) should represent Apis-specific genes. Conclusions The versatile and cost-efficient ORESTES approach produced minilibraries for honey bee life cycle stages. Such information on central gene regions contributes to genome annotation and also lends itself to cross-transcriptome comparisons to reveal evolutionary trends in insect genomes.
Collapse
|
38
|
Schadt EE, Edwards SW, GuhaThakurta D, Holder D, Ying L, Svetnik V, Leonardson A, Hart KW, Russell A, Li G, Cavet G, Castle J, McDonagh P, Kan Z, Chen R, Kasarskis A, Margarint M, Caceres RM, Johnson JM, Armour CD, Garrett-Engele PW, Tsinoremas NF, Shoemaker DD. A comprehensive transcript index of the human genome generated using microarrays and computational approaches. Genome Biol 2004; 5:R73. [PMID: 15461792 PMCID: PMC545593 DOI: 10.1186/gb-2004-5-10-r73] [Citation(s) in RCA: 82] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2004] [Revised: 07/07/2004] [Accepted: 08/16/2004] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND Computational and microarray-based experimental approaches were used to generate a comprehensive transcript index for the human genome. Oligonucleotide probes designed from approximately 50,000 known and predicted transcript sequences from the human genome were used to survey transcription from a diverse set of 60 tissues and cell lines using ink-jet microarrays. Further, expression activity over at least six conditions was more generally assessed using genomic tiling arrays consisting of probes tiled through a repeat-masked version of the genomic sequence making up chromosomes 20 and 22. RESULTS The combination of microarray data with extensive genome annotations resulted in a set of 28,456 experimentally supported transcripts. This set of high-confidence transcripts represents the first experimentally driven annotation of the human genome. In addition, the results from genomic tiling suggest that a large amount of transcription exists outside of annotated regions of the genome and serves as an example of how this activity could be measured on a genome-wide scale. CONCLUSIONS These data represent one of the most comprehensive assessments of transcriptional activity in the human genome and provide an atlas of human gene expression over a unique set of gene predictions. Before the annotation of the human genome is considered complete, however, the previously unannotated transcriptional activity throughout the genome must be fully characterized.
Collapse
Affiliation(s)
- Eric E Schadt
- Rosetta Inpharmatics LLC, 12040 115th Avenue NE, Kirkland, WA 98034, USA
| | - Stephen W Edwards
- Rosetta Inpharmatics LLC, 12040 115th Avenue NE, Kirkland, WA 98034, USA
| | | | - Dan Holder
- Merck Research Laboratories, W42-213 Sumneytown Pike, POB 4, Westpoint, PA 19846, USA
| | - Lisa Ying
- Merck Research Laboratories, W42-213 Sumneytown Pike, POB 4, Westpoint, PA 19846, USA
| | - Vladimir Svetnik
- Merck Research Laboratories, W42-213 Sumneytown Pike, POB 4, Westpoint, PA 19846, USA
| | - Amy Leonardson
- Rosetta Inpharmatics LLC, 12040 115th Avenue NE, Kirkland, WA 98034, USA
| | - Kyle W Hart
- Rally Scientific, 41 Fayette Street, Suite 1, Watertown, MA 02472, USA
| | - Archie Russell
- Rosetta Inpharmatics LLC, 12040 115th Avenue NE, Kirkland, WA 98034, USA
| | - Guoya Li
- Rosetta Inpharmatics LLC, 12040 115th Avenue NE, Kirkland, WA 98034, USA
| | - Guy Cavet
- Rosetta Inpharmatics LLC, 12040 115th Avenue NE, Kirkland, WA 98034, USA
| | - John Castle
- Rosetta Inpharmatics LLC, 12040 115th Avenue NE, Kirkland, WA 98034, USA
| | - Paul McDonagh
- Amgen Inc, 1201 Amgen Court W, Seattle, WA 98119, USA
| | - Zhengyan Kan
- Rosetta Inpharmatics LLC, 12040 115th Avenue NE, Kirkland, WA 98034, USA
| | - Ronghua Chen
- Rosetta Inpharmatics LLC, 12040 115th Avenue NE, Kirkland, WA 98034, USA
| | - Andrew Kasarskis
- Rosetta Inpharmatics LLC, 12040 115th Avenue NE, Kirkland, WA 98034, USA
| | - Mihai Margarint
- Rosetta Inpharmatics LLC, 12040 115th Avenue NE, Kirkland, WA 98034, USA
| | - Ramon M Caceres
- Rosetta Inpharmatics LLC, 12040 115th Avenue NE, Kirkland, WA 98034, USA
| | - Jason M Johnson
- Rosetta Inpharmatics LLC, 12040 115th Avenue NE, Kirkland, WA 98034, USA
| | | | | | | | - Daniel D Shoemaker
- Rosetta Inpharmatics LLC, 12040 115th Avenue NE, Kirkland, WA 98034, USA
| |
Collapse
|
39
|
Reis EM, Nakaya HI, Louro R, Canavez FC, Flatschart AVF, Almeida GT, Egidio CM, Paquola AC, Machado AA, Festa F, Yamamoto D, Alvarenga R, da Silva CC, Brito GC, Simon SD, Moreira-Filho CA, Leite KR, Camara-Lopes LH, Campos FS, Gimba E, Vignal GM, El-Dorry H, Sogayar MC, Barcinski MA, da Silva AM, Verjovski-Almeida S. Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer. Oncogene 2004; 23:6684-92. [PMID: 15221013 DOI: 10.1038/sj.onc.1207880] [Citation(s) in RCA: 123] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
A large fraction of transcripts are expressed antisense to introns of known genes in the human genome. Here we show the construction and use of a cDNA microarray platform enriched in intronic transcripts to assess their biological relevance in pathological conditions. To validate the approach, prostate cancer was used as a model, and 27 patient tumor samples with Gleason scores ranging from 5 to 10 were analyzed. We find that a considerably higher fraction (6.6%, [23/346]) of intronic transcripts are significantly correlated (P< or =0.001) to the degree of prostate tumor differentiation (Gleason score) when compared to transcripts from unannotated genomic regions (1%, [6/539]) or from exons of known genes (2%, [27/1369]). Among the top twelve transcripts most correlated to tumor differentiation, six are antisense intronic messages as shown by orientation-specific RT-PCR or Northern blot analysis with strand-specific riboprobe. Orientation-specific real-time RT-PCR with six tumor samples, confirmed the correlation (P=0.024) between the low/high degrees of tumor differentiation and antisense intronic RASSF1 transcript levels. The need to use intron arrays to reveal the transcriptome profile of antisense intronic RNA in cancer has clearly emerged.
Collapse
Affiliation(s)
- Eduardo M Reis
- Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, 05508-900 São Paulo, SP, Brasil
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Verjovski-Almeida S, Leite LCC, Dias-Neto E, Menck CFM, Wilson RA. Schistosome transcriptome: insights and perspectives for functional genomics. Trends Parasitol 2004; 20:304-8. [PMID: 15193558 DOI: 10.1016/j.pt.2004.04.012] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
41
|
da Mota AF, Sonstegard TS, Van Tassell CP, Shade LL, Matukumalli LK, Wood DL, Capuco AV, Brito MAP, Connor EE, Martinez ML, Coutinho LL. Characterization of open reading frame-expressed sequence tags generated from Bos indicus and B. taurus mammary gland cDNA libraries. Anim Genet 2004; 35:213-9. [PMID: 15147393 DOI: 10.1111/j.1365-2052.2004.01139.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Sequence-based gene expression data are used to interpret results from functional genomic and proteomics studies. Although more than 300 000 bovine-expressed sequence tags (ESTs) are available in public databases, a more thorough and directed sampling of the expressed genome is needed to identify new transcripts and improve assembly and annotation of existing transcript sequences. Accordingly, we examined the utility of constructing cDNA libraries synthesized by arbitrarily primed RT-PCR of mRNA from tissues not well represented in the publicly available bovine EST database. A total of 33 cDNA libraries were constructed from healthy and infected mammary gland tissues of Brazilian Gir and Holstein cattle. This series of libraries was used to generate 6481 open reading frame-expressed sequence tags (ORESTES) that assembled into 1798 unique sequence elements of which, 1157 did not significantly match sequence assemblies available in the Bos taurus gene index. However, a total of 264 of these 1157 sequence elements aligned with mouse and human expressed sequences demonstrating that ORESTES is an effective resource for discovery of novel expressed sequences in cattle. Furthermore, comparison of the alignment position of bovine ORESTES-derived sequence elements to human gene reference sequences suggested that the priming events for cDNA synthesis more often occurred at the central portion of a transcript, which may have contributed to the relatively high rate of novel sequence discovery.
Collapse
Affiliation(s)
- A F da Mota
- USDA, ARS Bovine Functional Genomics Laboratory, Beltsville Agricultural Research Institute (BARC) - East, Beltsville, MD, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Sogayar MC, Camargo AA, Bettoni F, Carraro DM, Pires LC, Parmigiani RB, Ferreira EN, de Sá Moreira E, do Rosário D de O Latorre M, Simpson AJG, Cruz LO, Degaki TL, Festa F, Massirer KB, Sogayar MC, Filho FC, Camargo LP, Cunha MAV, De Souza SJ, Faria M, Giuliatti S, Kopp L, de Oliveira PSL, Paiva PB, Pereira AA, Pinheiro DG, Puga RD, S de Souza JE, Albuquerque DM, Andrade LEC, Baia GS, Briones MRS, Cavaleiro-Luna AMS, Cerutti JM, Costa FF, Costanzi-Strauss E, Espreafico EM, Ferrasi AC, Ferro ES, Fortes MAHZ, Furchi JRF, Giannella-Neto D, Goldman GH, Goldman MHS, Gruber A, Guimarães GS, Hackel C, Henrique-Silva F, Kimura ET, Leoni SG, Macedo C, Malnic B, Manzini B CV, Marie SKN, Martinez-Rossi NM, Menossi M, Miracca EC, Nagai MA, Nobrega FG, Nobrega MP, Oba-Shinjo SM, Oliveira MK, Orabona GM, Otsuka AY, Paço-Larson ML, Paixão BMC, Pandolfi JRC, Pardini MIMC, Passos Bueno MR, Passos GAS, Pesquero JB, Pessoa JG, Rahal P, Rainho CA, Reis CP, Ricca TI, Rodrigues V, Rogatto SR, Romano CM, Romeiro JG, Rossi A, Sá RG, Sales MM, Sant'Anna SC, Santarosa PL, Segato F, Silva WA, Silva IDCG, Silva NP, Soares-Costa A, Sonati MF, Strauss BE, Tajara EH, Valentini SR, Villanova FE, Ward LS, Zanette DL. A transcript finishing initiative for closing gaps in the human transcriptome. Genome Res 2004; 14:1413-23. [PMID: 15197164 PMCID: PMC442158 DOI: 10.1101/gr.2111304] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2003] [Accepted: 03/12/2004] [Indexed: 11/24/2022]
Abstract
We report the results of a transcript finishing initiative, undertaken for the purpose of identifying and characterizing novel human transcripts, in which RT-PCR was used to bridge gaps between paired EST clusters, mapped against the genomic sequence. Each pair of EST clusters selected for experimental validation was designated a transcript finishing unit (TFU). A total of 489 TFUs were selected for validation, and an overall efficiency of 43.1% was achieved. We generated a total of 59,975 bp of transcribed sequences organized into 432 exons, contributing to the definition of the structure of 211 human transcripts. The structure of several transcripts reported here was confirmed during the course of this project, through the generation of their corresponding full-length cDNA sequences. Nevertheless, for 21% of the validated TFUs, a full-length cDNA sequence is not yet available in public databases, and the structure of 69.2% of these TFUs was not correctly predicted by computer programs. The TF strategy provides a significant contribution to the definition of the complete catalog of human genes and transcripts, because it appears to be particularly useful for identification of low abundance transcripts expressed in a restricted set of tissues as well as for the delineation of gene boundaries and alternatively spliced isoforms.
Collapse
|
43
|
Chevreux B, Pfisterer T, Drescher B, Driesel AJ, Müller WEG, Wetter T, Suhai S. Using the miraEST assembler for reliable and automated mRNA transcript assembly and SNP detection in sequenced ESTs. Genome Res 2004; 14:1147-59. [PMID: 15140833 PMCID: PMC419793 DOI: 10.1101/gr.1917404] [Citation(s) in RCA: 798] [Impact Index Per Article: 39.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2003] [Accepted: 01/28/2004] [Indexed: 11/24/2022]
Abstract
We present an EST sequence assembler that specializes in reconstruction of pristine mRNA transcripts, while at the same time detecting and classifying single nucleotide polymorphisms (SNPs) occuring in different variations thereof. The assembler uses iterative multipass strategies centered on high-confidence regions within sequences and has a fallback strategy for using low-confidence regions when needed. It features special functions to assemble high numbers of highly similar sequences without prior masking, an automatic editor that edits and analyzes alignments by inspecting the underlying traces, and detection and classification of sequence properties like SNPs with a high specificity and a sensitivity down to one mutation per sequence. In addition, it includes possibilities to use incorrectly preprocessed sequences, routines to make use of additional sequencing information such as base-error probabilities, template insert sizes, strain information, etc., and functions to detect and resolve possible misassemblies. The assembler is routinely used for such various tasks as mutation detection in different cell types, similarity analysis of transcripts between organisms, and pristine assembly of sequences from various sources for oligo design in clinical microarray experiments.
Collapse
Affiliation(s)
- Bastien Chevreux
- Department of Molecular Biophysics, German Cancer Research Centre Heidelberg, 69120 Heidelberg, Germany.
| | | | | | | | | | | | | |
Collapse
|
44
|
Shirley MW, Ivens A, Gruber A, Madeira AMBN, Wan KL, Dear PH, Tomley FM. The Eimeria genome projects: a sequence of events. Trends Parasitol 2004; 20:199-201. [PMID: 15105014 DOI: 10.1016/j.pt.2004.02.005] [Citation(s) in RCA: 83] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- Martin W Shirley
- Institute for Animal Health, Compton Laboratory, Compton, Nr Newbury, Berkshire RG20 7NN, UK.
| | | | | | | | | | | | | |
Collapse
|
45
|
Imanishi T, Itoh T, Suzuki Y, O'Donovan C, Fukuchi S, Koyanagi KO, Barrero RA, Tamura T, Yamaguchi-Kabata Y, Tanino M, Yura K, Miyazaki S, Ikeo K, Homma K, Kasprzyk A, Nishikawa T, Hirakawa M, Thierry-Mieg J, Thierry-Mieg D, Ashurst J, Jia L, Nakao M, Thomas MA, Mulder N, Karavidopoulou Y, Jin L, Kim S, Yasuda T, Lenhard B, Eveno E, Suzuki Y, Yamasaki C, Takeda JI, Gough C, Hilton P, Fujii Y, Sakai H, Tanaka S, Amid C, Bellgard M, Bonaldo MDF, Bono H, Bromberg SK, Brookes AJ, Bruford E, Carninci P, Chelala C, Couillault C, de Souza SJ, Debily MA, Devignes MD, Dubchak I, Endo T, Estreicher A, Eyras E, Fukami-Kobayashi K, R. Gopinath G, Graudens E, Hahn Y, Han M, Han ZG, Hanada K, Hanaoka H, Harada E, Hashimoto K, Hinz U, Hirai M, Hishiki T, Hopkinson I, Imbeaud S, Inoko H, Kanapin A, Kaneko Y, Kasukawa T, Kelso J, Kersey P, Kikuno R, Kimura K, Korn B, Kuryshev V, Makalowska I, Makino T, Mano S, Mariage-Samson R, Mashima J, Matsuda H, Mewes HW, Minoshima S, Nagai K, Nagasaki H, Nagata N, Nigam R, Ogasawara O, Ohara O, Ohtsubo M, Okada N, Okido T, Oota S, Ota M, Ota T, Otsuki T, Piatier-Tonneau D, Poustka A, Ren SX, Saitou N, Sakai K, Sakamoto S, Sakate R, Schupp I, Servant F, Sherry S, Shiba R, Shimizu N, Shimoyama M, Simpson AJ, Soares B, Steward C, Suwa M, Suzuki M, Takahashi A, Tamiya G, Tanaka H, Taylor T, Terwilliger JD, Unneberg P, Veeramachaneni V, Watanabe S, Wilming L, Yasuda N, Yoo HS, Stodolsky M, Makalowski W, Go M, Nakai K, Takagi T, Kanehisa M, Sakaki Y, Quackenbush J, Okazaki Y, Hayashizaki Y, Hide W, Chakraborty R, Nishikawa K, Sugawara H, Tateno Y, Chen Z, Oishi M, Tonellato P, Apweiler R, Okubo K, Wagner L, Wiemann S, Strausberg RL, Isogai T, Auffray C, Nomura N, Gojobori T, Sugano S. Integrative annotation of 21,037 human genes validated by full-length cDNA clones. PLoS Biol 2004; 2:e162. [PMID: 15103394 PMCID: PMC393292 DOI: 10.1371/journal.pbio.0020162] [Citation(s) in RCA: 267] [Impact Index Per Article: 13.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2003] [Accepted: 04/01/2004] [Indexed: 01/08/2023] Open
Abstract
The human genome sequence defines our inherent biological potential; the realization of the biology encoded therein requires knowledge of the function of each gene. Currently, our knowledge in this area is still limited. Several lines of investigation have been used to elucidate the structure and function of the genes in the human genome. Even so, gene prediction remains a difficult task, as the varieties of transcripts of a gene may vary to a great extent. We thus performed an exhaustive integrative characterization of 41,118 full-length cDNAs that capture the gene transcripts as complete functional cassettes, providing an unequivocal report of structural and functional diversity at the gene level. Our international collaboration has validated 21,037 human gene candidates by analysis of high-quality full-length cDNA clones through curation using unified criteria. This led to the identification of 5,155 new gene candidates. It also manifested the most reliable way to control the quality of the cDNA clones. We have developed a human gene database, called the H-Invitational Database (H-InvDB; http://www.h-invitational.jp/). It provides the following: integrative annotation of human genes, description of gene structures, details of novel alternative splicing isoforms, non-protein-coding RNAs, functional domains, subcellular localizations, metabolic pathways, predictions of protein three-dimensional structure, mapping of known single nucleotide polymorphisms (SNPs), identification of polymorphic microsatellite repeats within human genes, and comparative results with mouse full-length cDNAs. The H-InvDB analysis has shown that up to 4% of the human genome sequence (National Center for Biotechnology Information build 34 assembly) may contain misassembled or missing regions. We found that 6.5% of the human gene candidates (1,377 loci) did not have a good protein-coding open reading frame, of which 296 loci are strong candidates for non-protein-coding RNA genes. In addition, among 72,027 uniquely mapped SNPs and insertions/deletions localized within human genes, 13,215 nonsynonymous SNPs, 315 nonsense SNPs, and 452 indels occurred in coding regions. Together with 25 polymorphic microsatellite repeats present in coding regions, they may alter protein structure, causing phenotypic effects or resulting in disease. The H-InvDB platform represents a substantial contribution to resources needed for the exploration of human biology and pathology.
Collapse
Affiliation(s)
- Tadashi Imanishi
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
| | - Takeshi Itoh
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 2Bioinformatics Laboratory, Genome Research Department, National Institute of Agrobiological SciencesIbarakiJapan
| | - Yutaka Suzuki
- 3Human Genome Center, The Institute of Medical Science, The University of TokyoTokyoJapan
- 68Department of Medical Genome Sciences, Graduate School of Frontier Sciences, University of TokyoTokyoJapan
| | - Claire O'Donovan
- 4EMBL Outstation—European Bioinformatics Institute, Wellcome Trust Genome CampusCambridgeUnited Kingdom
| | - Satoshi Fukuchi
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | | | - Roberto A Barrero
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Takuro Tamura
- 7Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics ConsortiumTokyoJapan
- 8BITS CompanyShizuokaJapan
| | - Yumi Yamaguchi-Kabata
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
| | - Motohiko Tanino
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 7Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics ConsortiumTokyoJapan
| | - Kei Yura
- 9Quantum Bioinformatics Group, Center for Promotion of Computational Science and Engineering, Japan Atomic Energy Research InstituteKyotoJapan
| | - Satoru Miyazaki
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Kazuho Ikeo
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Keiichi Homma
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Arek Kasprzyk
- 4EMBL Outstation—European Bioinformatics Institute, Wellcome Trust Genome CampusCambridgeUnited Kingdom
| | - Tetsuo Nishikawa
- 10Reverse Proteomics Research InstituteChibaJapan
- 11Central Research Laboratory, HitachiTokyoJapan
| | - Mika Hirakawa
- 12Bioinformatics Center, Institute for Chemical Research, Kyoto UniversityKyotoJapan
| | - Jean Thierry-Mieg
- 13National Center for Biotechnology Information, National Library of Medicine, National Institutes of HealthBethesda, MarylandUnited States of America
- 14Centre National de la Recherche Scientifique (CNRS), Laboratoire de Physique MathematiqueMontpellierFrance
| | - Danielle Thierry-Mieg
- 13National Center for Biotechnology Information, National Library of Medicine, National Institutes of HealthBethesda, MarylandUnited States of America
- 14Centre National de la Recherche Scientifique (CNRS), Laboratoire de Physique MathematiqueMontpellierFrance
| | - Jennifer Ashurst
- 15The Wellcome Trust Sanger Institute, Wellcome Trust Genome CampusCambridgeUnited Kingdom
| | - Libin Jia
- 16National Cancer Institute, National Institutes of HealthBethesda, MarylandUnited States of America
| | - Mitsuteru Nakao
- 3Human Genome Center, The Institute of Medical Science, The University of TokyoTokyoJapan
| | - Michael A Thomas
- 17Department of Biological Sciences, Idaho State UniversityPocatello, IdahoUnited States of America
| | - Nicola Mulder
- 4EMBL Outstation—European Bioinformatics Institute, Wellcome Trust Genome CampusCambridgeUnited Kingdom
| | - Youla Karavidopoulou
- 4EMBL Outstation—European Bioinformatics Institute, Wellcome Trust Genome CampusCambridgeUnited Kingdom
| | - Lihua Jin
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Sangsoo Kim
- 18Korea Research Institute of Bioscience and BiotechnologyTaejeonKorea
| | | | - Boris Lenhard
- 19Center for Genomics and Bioinformatics, Karolinska InstitutetStockholmSweden
| | - Eric Eveno
- 20Genexpress—CNRS—Functional Genomics and Systemic Biology for HealthVillejuif CedexFrance
- 21Sino-French Laboratory in Life Sciences and GenomicsShanghaiChina
| | - Yoshiyuki Suzuki
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Chisato Yamasaki
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
| | - Jun-ichi Takeda
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
| | - Craig Gough
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 7Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics ConsortiumTokyoJapan
| | - Phillip Hilton
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 7Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics ConsortiumTokyoJapan
| | - Yasuyuki Fujii
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 7Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics ConsortiumTokyoJapan
| | - Hiroaki Sakai
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 7Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics ConsortiumTokyoJapan
- 22Tokyo Research Laboratories, Kyowa Hakko Kogyo CompanyTokyoJapan
| | - Susumu Tanaka
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 7Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics ConsortiumTokyoJapan
| | - Clara Amid
- 23MIPS—Institute for Bioinformatics, GSF—National Research Center for Environment and HealthNeuherbergGermany
| | - Matthew Bellgard
- 24Centre for Bioinformatics and Biological Computing, School of Information Technology, Murdoch UniversityMurdoch, Western AustraliaAustralia
| | - Maria de Fatima Bonaldo
- 25Medical Education and Biomedical Research Facility, University of IowaIowa City, IowaUnited States of America
| | - Hidemasa Bono
- 26Genome Exploration Research Group, RIKEN Genomic Sciences Center, RIKEN Yokohama InstituteKanagawaJapan
| | - Susan K Bromberg
- 27Medical College of Wisconsin, MilwaukeeWisconsinUnited States of America
| | - Anthony J Brookes
- 19Center for Genomics and Bioinformatics, Karolinska InstitutetStockholmSweden
| | - Elspeth Bruford
- 28HUGO Gene Nomenclature Committee, University College LondonLondonUnited Kingdom
| | | | - Claude Chelala
- 20Genexpress—CNRS—Functional Genomics and Systemic Biology for HealthVillejuif CedexFrance
| | - Christine Couillault
- 20Genexpress—CNRS—Functional Genomics and Systemic Biology for HealthVillejuif CedexFrance
- 21Sino-French Laboratory in Life Sciences and GenomicsShanghaiChina
| | | | - Marie-Anne Debily
- 20Genexpress—CNRS—Functional Genomics and Systemic Biology for HealthVillejuif CedexFrance
| | | | - Inna Dubchak
- 32Lawrence Berkeley National Laboratory, BerkeleyCaliforniaUnited States of America
| | - Toshinori Endo
- 33Department of Bioinformatics, Medical Research Institute, Tokyo Medical and Dental UniversityTokyoJapan
| | | | - Eduardo Eyras
- 15The Wellcome Trust Sanger Institute, Wellcome Trust Genome CampusCambridgeUnited Kingdom
| | - Kaoru Fukami-Kobayashi
- 35Bioresource Information Division, RIKEN BioResource Center, RIKEN Tsukuba InstituteIbarakiJapan
| | - Gopal R. Gopinath
- 36Genome Knowledgebase, Cold Spring Harbor LaboratoryCold Spring Harbor, New YorkUnited States of America
| | - Esther Graudens
- 20Genexpress—CNRS—Functional Genomics and Systemic Biology for HealthVillejuif CedexFrance
- 21Sino-French Laboratory in Life Sciences and GenomicsShanghaiChina
| | - Yoonsoo Hahn
- 18Korea Research Institute of Bioscience and BiotechnologyTaejeonKorea
| | - Michael Han
- 23MIPS—Institute for Bioinformatics, GSF—National Research Center for Environment and HealthNeuherbergGermany
| | - Ze-Guang Han
- 21Sino-French Laboratory in Life Sciences and GenomicsShanghaiChina
- 37Chinese National Human Genome Center at ShanghaiShanghaiChina
| | - Kousuke Hanada
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Hideki Hanaoka
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
| | - Erimi Harada
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 7Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics ConsortiumTokyoJapan
| | - Katsuyuki Hashimoto
- 38Division of Genetic Resources, National Institute of Infectious DiseasesTokyoJapan
| | - Ursula Hinz
- 34Swiss Institute of BioinformaticsGenevaSwitzerland
| | - Momoki Hirai
- 39Graduate School of Frontier Sciences, Department of Integrated Biosciences, University of TokyoChibaJapan
| | - Teruyoshi Hishiki
- 40Functional Genomics Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
| | - Ian Hopkinson
- 41Department of Primary Care and Population Sciences, Royal Free University College Medical School, University College LondonLondonUnited Kingdom
- 42Clinical and Molecular Genetics Unit, The Institute of Child HealthLondonUnited Kingdom
| | - Sandrine Imbeaud
- 20Genexpress—CNRS—Functional Genomics and Systemic Biology for HealthVillejuif CedexFrance
- 21Sino-French Laboratory in Life Sciences and GenomicsShanghaiChina
| | - Hidetoshi Inoko
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 7Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics ConsortiumTokyoJapan
- 43Department of Genetic Information, Division of Molecular Life Science, School of Medicine, Tokai UniversityKanagawaJapan
| | - Alexander Kanapin
- 4EMBL Outstation—European Bioinformatics Institute, Wellcome Trust Genome CampusCambridgeUnited Kingdom
| | - Yayoi Kaneko
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 7Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics ConsortiumTokyoJapan
| | - Takeya Kasukawa
- 26Genome Exploration Research Group, RIKEN Genomic Sciences Center, RIKEN Yokohama InstituteKanagawaJapan
| | - Janet Kelso
- 44South African National Bioinformatics Institute, University of the Western CapeBellvilleSouth Africa
| | - Paul Kersey
- 4EMBL Outstation—European Bioinformatics Institute, Wellcome Trust Genome CampusCambridgeUnited Kingdom
| | | | | | - Bernhard Korn
- 46RZPD Resource Center for Genome ResearchHeidelbergGermany
| | - Vladimir Kuryshev
- 47Molecular Genome Analysis, German Cancer Research Center-DKFZHeidelbergGermany
| | - Izabela Makalowska
- 48Pennsylvania State UniversityUniversity Park, PennsylvaniaUnited States of America
| | - Takashi Makino
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Shuhei Mano
- 43Department of Genetic Information, Division of Molecular Life Science, School of Medicine, Tokai UniversityKanagawaJapan
| | - Regine Mariage-Samson
- 20Genexpress—CNRS—Functional Genomics and Systemic Biology for HealthVillejuif CedexFrance
| | - Jun Mashima
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Hideo Matsuda
- 49Department of Bioinformatic Engineering, Graduate School of Information Science and Technology, Osaka UniversityOsakaJapan
| | - Hans-Werner Mewes
- 23MIPS—Institute for Bioinformatics, GSF—National Research Center for Environment and HealthNeuherbergGermany
| | - Shinsei Minoshima
- 50Medical Photobiology Department, Photon Medical Research Center, Hamamatsu University School of MedicineShizuokaJapan
- 52Department of Molecular Biology, Keio University School of MedicineTokyoJapan
| | | | - Hideki Nagasaki
- 51Computational Biology Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
| | - Naoki Nagata
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
| | - Rajni Nigam
- 27Medical College of Wisconsin, MilwaukeeWisconsinUnited States of America
| | - Osamu Ogasawara
- 3Human Genome Center, The Institute of Medical Science, The University of TokyoTokyoJapan
| | | | - Masafumi Ohtsubo
- 52Department of Molecular Biology, Keio University School of MedicineTokyoJapan
| | - Norihiro Okada
- 53Department of Biological Sciences, Graduate School of Bioscience and Biotechnology, Tokyo Institute of TechnologyKanagawaJapan
| | - Toshihisa Okido
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Satoshi Oota
- 35Bioresource Information Division, RIKEN BioResource Center, RIKEN Tsukuba InstituteIbarakiJapan
| | - Motonori Ota
- 54Global Scientific Information and Computing Center, Tokyo Institute of TechnologyTokyoJapan
| | - Toshio Ota
- 22Tokyo Research Laboratories, Kyowa Hakko Kogyo CompanyTokyoJapan
| | - Tetsuji Otsuki
- 55Molecular Biology Laboratory, Medicinal Research Laboratories, Taisho Pharmaceutical CompanySaitamaJapan
| | | | - Annemarie Poustka
- 47Molecular Genome Analysis, German Cancer Research Center-DKFZHeidelbergGermany
| | - Shuang-Xi Ren
- 21Sino-French Laboratory in Life Sciences and GenomicsShanghaiChina
- 37Chinese National Human Genome Center at ShanghaiShanghaiChina
| | - Naruya Saitou
- 56Department of Population Genetics, National Institute of GeneticsShizuokaJapan
| | - Katsunaga Sakai
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Shigetaka Sakamoto
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Ryuichi Sakate
- 39Graduate School of Frontier Sciences, Department of Integrated Biosciences, University of TokyoChibaJapan
| | - Ingo Schupp
- 47Molecular Genome Analysis, German Cancer Research Center-DKFZHeidelbergGermany
| | - Florence Servant
- 4EMBL Outstation—European Bioinformatics Institute, Wellcome Trust Genome CampusCambridgeUnited Kingdom
| | - Stephen Sherry
- 13National Center for Biotechnology Information, National Library of Medicine, National Institutes of HealthBethesda, MarylandUnited States of America
| | - Rie Shiba
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 7Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics ConsortiumTokyoJapan
| | - Nobuyoshi Shimizu
- 52Department of Molecular Biology, Keio University School of MedicineTokyoJapan
| | - Mary Shimoyama
- 27Medical College of Wisconsin, MilwaukeeWisconsinUnited States of America
| | | | - Bento Soares
- 25Medical Education and Biomedical Research Facility, University of IowaIowa City, IowaUnited States of America
| | - Charles Steward
- 15The Wellcome Trust Sanger Institute, Wellcome Trust Genome CampusCambridgeUnited Kingdom
| | - Makiko Suwa
- 51Computational Biology Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
| | - Mami Suzuki
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Aiko Takahashi
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 7Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics ConsortiumTokyoJapan
| | - Gen Tamiya
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 7Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics ConsortiumTokyoJapan
- 43Department of Genetic Information, Division of Molecular Life Science, School of Medicine, Tokai UniversityKanagawaJapan
| | - Hiroshi Tanaka
- 33Department of Bioinformatics, Medical Research Institute, Tokyo Medical and Dental UniversityTokyoJapan
| | - Todd Taylor
- 57Human Genome Research Group, Genomic Sciences Center, RIKEN Yokohama InstituteKanagawaJapan
| | - Joseph D Terwilliger
- 58Columbia University and Columbia Genome CenterNew York, New YorkUnited States of America
| | - Per Unneberg
- 59Department of Biotechnology, Royal Institute of TechnologyStockholmSweden
| | - Vamsi Veeramachaneni
- 48Pennsylvania State UniversityUniversity Park, PennsylvaniaUnited States of America
| | - Shinya Watanabe
- 3Human Genome Center, The Institute of Medical Science, The University of TokyoTokyoJapan
| | - Laurens Wilming
- 15The Wellcome Trust Sanger Institute, Wellcome Trust Genome CampusCambridgeUnited Kingdom
| | - Norikazu Yasuda
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 7Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics ConsortiumTokyoJapan
| | - Hyang-Sook Yoo
- 18Korea Research Institute of Bioscience and BiotechnologyTaejeonKorea
| | - Marvin Stodolsky
- 60Biology Division and Genome Task Group, Office of Biological and Environmental Research, United States Department of EnergyWashington, D.CUnited States of America
| | - Wojciech Makalowski
- 48Pennsylvania State UniversityUniversity Park, PennsylvaniaUnited States of America
| | - Mitiko Go
- 61Faculty of Bio-Science, Nagahama Institute of Bio-Science and TechnologyShigaJapan
| | - Kenta Nakai
- 3Human Genome Center, The Institute of Medical Science, The University of TokyoTokyoJapan
| | - Toshihisa Takagi
- 3Human Genome Center, The Institute of Medical Science, The University of TokyoTokyoJapan
| | - Minoru Kanehisa
- 12Bioinformatics Center, Institute for Chemical Research, Kyoto UniversityKyotoJapan
| | - Yoshiyuki Sakaki
- 3Human Genome Center, The Institute of Medical Science, The University of TokyoTokyoJapan
- 57Human Genome Research Group, Genomic Sciences Center, RIKEN Yokohama InstituteKanagawaJapan
| | - John Quackenbush
- 62Institute for Genomic ResearchRockville, MarylandUnited States of America
| | - Yasushi Okazaki
- 26Genome Exploration Research Group, RIKEN Genomic Sciences Center, RIKEN Yokohama InstituteKanagawaJapan
| | - Yoshihide Hayashizaki
- 26Genome Exploration Research Group, RIKEN Genomic Sciences Center, RIKEN Yokohama InstituteKanagawaJapan
| | - Winston Hide
- 44South African National Bioinformatics Institute, University of the Western CapeBellvilleSouth Africa
| | - Ranajit Chakraborty
- 63Center for Genome Information, Department of Environmental Health, University of CincinnatiCincinnati, OhioUnited States of America
| | - Ken Nishikawa
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Hideaki Sugawara
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Yoshio Tateno
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
| | - Zhu Chen
- 21Sino-French Laboratory in Life Sciences and GenomicsShanghaiChina
- 37Chinese National Human Genome Center at ShanghaiShanghaiChina
- 64State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui-Jin Hospital, Shanghai Second Medical UniversityShanghaiChina
| | | | - Peter Tonellato
- 65PointOne SystemsWauwatosa, WisconsinUnited States of America
| | - Rolf Apweiler
- 4EMBL Outstation—European Bioinformatics Institute, Wellcome Trust Genome CampusCambridgeUnited Kingdom
| | - Kousaku Okubo
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
- 40Functional Genomics Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
| | - Lukas Wagner
- 13National Center for Biotechnology Information, National Library of Medicine, National Institutes of HealthBethesda, MarylandUnited States of America
| | - Stefan Wiemann
- 47Molecular Genome Analysis, German Cancer Research Center-DKFZHeidelbergGermany
| | - Robert L Strausberg
- 16National Cancer Institute, National Institutes of HealthBethesda, MarylandUnited States of America
| | - Takao Isogai
- 10Reverse Proteomics Research InstituteChibaJapan
- 66Graduate School of Life and Environmental Sciences, University of TsukubaIbarakiJapan
| | - Charles Auffray
- 20Genexpress—CNRS—Functional Genomics and Systemic Biology for HealthVillejuif CedexFrance
- 21Sino-French Laboratory in Life Sciences and GenomicsShanghaiChina
| | - Nobuo Nomura
- 40Functional Genomics Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
| | - Takashi Gojobori
- 1Integrated Database Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 5Center for Information Biology and DNA Data Bank of Japan, National Institute of GeneticsShizuokaJapan
- 67Department of Genetics, Graduate University for Advanced StudiesShizuokaJapan
| | - Sumio Sugano
- 3Human Genome Center, The Institute of Medical Science, The University of TokyoTokyoJapan
- 40Functional Genomics Group, Biological Information Research Center, National Institute of Advanced Industrial Science and TechnologyTokyoJapan
- 68Department of Medical Genome Sciences, Graduate School of Frontier Sciences, University of TokyoTokyoJapan
| |
Collapse
|
46
|
Louro R, Nakaya HI, Paquola ACM, Martins EAL, da Silva AM, Verjovski-Almeida S, Reis EM. RASL11A, member of a novel small monomeric GTPase gene family, is down-regulated in prostate tumors. Biochem Biophys Res Commun 2004; 316:618-27. [PMID: 15033445 DOI: 10.1016/j.bbrc.2004.02.091] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2004] [Indexed: 10/26/2022]
Abstract
We performed a genome-wide search for novel loci encoding for Ras-related proteins based on the genome mapping coordinates of the cancer-derived EST dataset at GenBank. Partial sequences from two novel human genes were identified and subsequently used for full length transcript cloning. RASL11A and ARL9 belong to two novel subfamilies coding for small GTPases that we found to be highly conserved among eukaryotes. The Arl9/Arl10 subfamily displays a conserved interswitch toggle that places it evolutionarily closer to the Arf family. Rasl11 proteins are more closely related to the Ras branch of GTPases. All orthologues newly identified here exhibit an Asn residue in place of the highly conserved Thr35 of the G domain, suggesting that the universal switch mechanism of small GTPases may be structurally different in this subfamily. We determined by Northern blot that RASL11A is transcribed in several human tissues and that it is down-regulated in prostate tumors as measured by quantitative real-time PCR. These results highlight a previously uncharacterized subfamily of Ras-related genes that may have a tumor suppressor role in prostate cancer.
Collapse
Affiliation(s)
- Rodrigo Louro
- Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, 05508-900 São Paulo, SP, Brazil
| | | | | | | | | | | | | |
Collapse
|
47
|
Matsuo SE, Martins L, Leoni SG, Hajjar D, Ricarte-Filho JCM, Ebina KN, Kimura ET. Marcadores biológicos de tumores tiroidianos. ACTA ACUST UNITED AC 2004; 48:114-25. [PMID: 15611824 DOI: 10.1590/s0004-27302004000100013] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Um marcador biológico ideal deve ser específico e sensível para identificar o tipo tumoral e caracterizar o estágio da progressão neoplásica. Os tumores de tiróide originam-se de dois tipos celulares: 1) carcinoma medular originário de células parafoliculares; e 2) as neoplasias de células epiteliais foliculares, que incluem bócio, adenomas, carcinomas diferenciados (carcinoma papilífero e carcinoma folicular) e carcinoma indiferenciado (carcinoma anaplásico). O comportamento biológico distinto faz com que cada tipo tumoral necessite de uma conduta terapêutica específica. O conhecimento acumulado ao longo destes anos, utilizando métodos de biologia molecular e, mais recentemente, a genômica, identificou mutações específicas de câncer de tiróide e, atualmente, entendemos muito das alterações que ocorrem na expressão de fatores de crescimento, seus receptores e proteínas sinalizadoras intracelular nas neoplasias tiroidianas. Contudo, apesar desses, até o momento não dispomos de um marcador eficiente que auxilie no diagnóstico e prognóstico e, conseqüentemente, para indicação de uma terapêutica mais adequada. Nesta revisão, discutiremos os principais aspectos relacionados à tumorigênese tiroidiana, avaliando o potencial destes fatores como marcador em neoplasia folicular de tiróide.
Collapse
Affiliation(s)
- Sílvia E Matsuo
- Departamento de Histologia & Embriologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP
| | | | | | | | | | | | | |
Collapse
|
48
|
Sperisen P, Iseli C, Pagni M, Stevenson BJ, Bucher P, Jongeneel CV. trome, trEST and trGEN: databases of predicted protein sequences. Nucleic Acids Res 2004; 32:D509-11. [PMID: 14681469 PMCID: PMC308801 DOI: 10.1093/nar/gkh067] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
We previously introduced two new protein databases (trEST and trGEN) of hypothetical protein sequences predicted from EST and HTG sequences, respectively. Here, we present the updates made on these two databases plus a new database (trome), which uses alignments of EST data to HTG or full genomes to generate virtual transcripts and coding sequences. This new database is of higher quality and since it contains the information in a much denser format it is of much smaller size. These new databases are in a Swiss-Prot-like format and are updated on a weekly basis (trEST and trGEN) or every 3 months (trome). They can be downloaded by anonymous ftp from ftp://ftp.isrec.isb-sib.ch/pub/databases.
Collapse
Affiliation(s)
- Peter Sperisen
- Swiss Institute of Bioinformatics, Ludwig Institute for Cancer Research, Chemin des Boveresses 155, 1066 Epalinges s/Lausanne, Switzerland.
| | | | | | | | | | | |
Collapse
|
49
|
Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2004; 302:2141-4. [PMID: 14684825 DOI: 10.1126/science.1090100] [Citation(s) in RCA: 1121] [Impact Index Per Article: 56.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Alternative pre-messenger RNA (pre-mRNA) splicing plays important roles in development, physiology, and disease, and more than half of human genes are alternatively spliced. To understand the biological roles and regulation of alternative splicing across different tissues and stages of development, systematic methods are needed. Here, we demonstrate the use of microarrays to monitor splicing at every exon-exon junction in more than 10,000 multi-exon human genes in 52 tissues and cell lines. These genome-wide data provide experimental evidence and tissue distributions for thousands of known and novel alternative splicing events. Adding to previous studies, the results indicate that at least 74% of human multi-exon genes are alternatively spliced.
Collapse
Affiliation(s)
- Jason M Johnson
- Rosetta Inpharmatics LLC, Merck & Co., Inc., 12040 115th Avenue N.E., Kirkland, WA 98034, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Favre M, Butticaz C, Stevenson B, Jongeneel CV, Telenti A. High frequency of alternative splicing of human genes participating in the HIV-1 life cycle: a model using TSG101, betaTrCP, PPIA, INI1, NAF1, and PML. J Acquir Immune Defic Syndr 2003; 34:127-33. [PMID: 14526201 DOI: 10.1097/00126334-200310010-00002] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Alternative splicing may generate splice forms with different biologic roles or missing protein domains implicated in the interaction with HIV-1. To address this issue, 6 human genes were investigated-tumor suppressor gene 101 (TSG101), beta-transducin repeats containing protein (betaTrCP), peptidyl-proly cis-trans isomerase, cyclophilin A (PPIA), integrase interactor 1 protein (INI1), Nef-associated factor 1 (NAF1), and promyelacytic leukemia (PML)-involved in the viral life cycle and HIV-1 pathogenesis. All 6 genes presented alternative splicing, and a combined bioinformatic and reverse transcription polymerase chain reaction (RT-PCR) analysis identified 27 new variants for a total of 53 splice forms (an average of 9 variants per gene). The predicted frequency of the various splice forms based on expressed sequence tags (EST) analysis corresponded to the semiquantitative findings on RT-PCR analysis for the cell culture systems and for native CD4 cells investigated. Interindividual variation in the frequencies of various splice forms in CD4 T cells from blood donors was observed for INI1. Cell type-specific variation of splice pattern was observed for NAF1. Eight splice forms lacked or modified motifs implicated in the interaction with HIV-1, underscoring the potential interest of assessing alternative splicing when investigating viral cell biology and pathogenesis.
Collapse
Affiliation(s)
- Manuel Favre
- Division of Infectious Diseases and Institute of Microbiology, University Hospital of Lausanne, Switzerland
| | | | | | | | | |
Collapse
|